UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________

Form 10-Q

________________________

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from____to____.

Commission File Number 001-10932

________________________

WisdomTree, Inc.

(Exact name of registrant as specified in its charter)

________________________

   
Delaware 13-3487784

(State or other jurisdiction of

incorporation or organization)

(IRS Employer

Identification No.)

   

250 West 34th Street

3rd Floor

New York, New York

10119
(Address of principal executive offices) (Zip Code)

212-801-2080

(Registrant’s telephone number, including area code)

________________________

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered

Common Stock, $0.01 par value

WT

The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     
Large accelerated filer Accelerated filer
       
Non-accelerated filer Smaller reporting company
    Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

As of May 6, 2025, there were 147,031,329 shares of the registrant’s Common Stock, $0.01 par value per share, outstanding.

 
   
 

WISDOMTREE, INC.

Form 10-Q

For the Quarterly Period Ended March 31, 2025

TABLE OF CONTENTS

 

PART I: FINANCIAL INFORMATION 4
ITEM 1. FINANCIAL STATEMENTS 4
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 29
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 45
ITEM 4. CONTROLS AND PROCEDURES 46
PART II: OTHER INFORMATION 46
ITEM 1. LEGAL PROCEEDINGS 46
ITEM 1A. RISK FACTORS 46
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 46
ITEM 3. DEFAULTS UPON SENIOR SECURITIES 46
ITEM 4. MINE SAFETY DISCLOSURES 47
ITEM 5. OTHER INFORMATION 47
ITEM 6. EXHIBITS 48

 

 

Unless otherwise indicated, references to “the Company,” “we,” “us,” “our” and “WisdomTree” mean WisdomTree, Inc. and its subsidiaries.

 

WisdomTree®, WisdomTree Prime®, WisdomTree Connect™ and Modern Alpha® are trademarks of WisdomTree, Inc. in the United States and in other countries. All other trademarks are the property of their respective owners.

 2 
 Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q, or Report, contains forward-looking statements that are based on our management’s beliefs and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect our results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed in the section entitled “Risk Factors” included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. If one or more of these or other risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this Report and the documents that we reference in this Report and have filed with the U.S. Securities and Exchange Commission, or the SEC, as exhibits to this Report, completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements.

In particular, forward-looking statements in this Report may include statements about:

anticipated trends, conditions and investor sentiment in the global markets and exchange-traded products, or ETPs;
anticipated levels of inflows into and outflows out of our ETPs;
our ability to deliver favorable rates of return to investors;
competition in our business;
whether we will experience future growth;
our ability to develop new products and services and their potential for success;
our ability to maintain current vendors or find new vendors to provide services to us at favorable costs;
our ability to successfully implement our strategy relating to digital assets and blockchain-enabled financial services, including WisdomTree Prime and WisdomTree Connect, and achieve its objectives;
our ability to successfully operate and expand our business in non-U.S. markets;
the effect of laws and regulations that apply to our business; and
actions of activist stockholders.

The forward-looking statements in this Report represent our views as of the date of this Report. We anticipate that subsequent events and developments may cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. Therefore, these forward-looking statements do not represent our views as of any date other than the date of this Report.

 3 
 Table of Contents

PART I: FINANCIAL INFORMATION

ITEM 1.FINANCIAL STATEMENTS

WisdomTree, Inc. and Subsidiaries

Consolidated Balance Sheets

(In Thousands, Except Per Share Amounts)

  

March 31,

2025

  December 31,
2024
Assets  (unaudited)     
Current assets:          
Cash, cash equivalents and restricted cash (including $11,282 invested in the WisdomTree Government Money Market Digital Fund at March 31, 2025 and December 31, 2024) (Note 3)  $170,373   $181,191 
Financial instruments owned, at fair value (including $78,590 and $78,540 invested in WisdomTree products at March 31, 2025 and December 31, 2024, respectively) (Note 5)   85,294    85,439 
Accounts receivable (including $35,440 and $34,959 due from related parties at March 31, 2025 and December 31, 2024, respectively)   46,125    44,866 
Income taxes receivable   3,400    
 
Prepaid expenses   6,922    5,340 
Other current assets   1,377    1,542 
Total current assets   313,491    318,378 
Fixed assets, net   302    336 
Deferred tax assets, net (Note 18)   5,622    11,656 
Investments (Note 6)   9,237    8,922 
Right of use assets—operating leases (Note 10)   583    880 
Goodwill (Note 20)   86,841    86,841 
Intangible assets, net (Note 20)   606,034    605,896 
Other noncurrent assets   746    631 
Total assets  $1,022,856   $1,033,540 
Liabilities and stockholders’ equity          
Liabilities          
Current liabilities:          
Fund management and administration payable  $34,513   $31,135 
Compensation and benefits payable   11,803    39,701 
Payable to Gold Bullion Holdings (Jersey) Limited (“GBH”) (Note 9)   14,804    14,804 
Income taxes payable   
    724 
Operating lease liabilities (Note 10)   493    709 
Accounts payable and other liabilities   20,251    22,124 
Total current liabilities   81,864    109,197 
Convertible notes (Note 8)   512,657    512,033 
Payable to GBH (Note 9)   12,615    12,159 
Operating lease liabilities (Note 10)   89    171 
Total liabilities   607,225    633,560 
Contingencies (Note 11)   
 
    
 
 
Stockholders’ equity          
Preferred stock, par value $0.01; 2,000 shares authorized   
    
 
Common stock, par value $0.01; 400,000 shares authorized; issued and outstanding: 147,034 and 146,102 at March 31, 2025 and December 31, 2024, respectively   1,470    1,461 
Additional paid-in capital   263,818    270,303 
Accumulated other comprehensive income/(loss)   299    (1,607)
Retained earnings   150,044    129,823 
Total stockholders’ equity   415,631    399,980 
Total liabilities and stockholders’ equity  $1,022,856    1,033,540 

The accompanying notes are an integral part of these consolidated financial statements.

 4 
 Table of Contents

WisdomTree, Inc. and Subsidiaries

Consolidated Statements of Operations

(In Thousands, Except Per Share Amounts)

(Unaudited)

  

Three Months Ended

March 31,

   2025  2024
Operating Revenues:          
Advisory fees  $99,549   $92,501 
Other revenues   8,533    4,337 
Total revenues   108,082    96,838 
Operating Expenses:          
Compensation and benefits   33,788    31,054 
Fund management and administration   20,714    19,962 
Marketing and advertising   4,813    4,408 
Sales and business development   4,137    3,611 
Professional fees   2,782    3,630 
Occupancy, communications and equipment   1,482    1,210 
Depreciation and amortization   540    383 
Third-party distribution fees   3,112    2,307 
Other   2,552    2,323 
Total operating expenses   73,920    68,888 
Operating income   34,162    27,950 
Other Income/(Expenses):          
Interest expense   (5,441)   (4,128)
Interest income   1,897    1,398 
Other losses and gains, net   (250)   2,592 
Income before income taxes   30,368    27,812 
Income tax expense   5,739    5,701 
Net income  $24,629   $22,111 
Earnings per share—basic  $0.17   $0.14 
Earnings per share—diluted  $0.17   $0.13 
Weighted-average common shares—basic   142,580    146,464 
Weighted-average common shares—diluted   146,545    165,268 
Cash dividends declared per common share  $0.03   $0.03 

The accompanying notes are an integral part of these consolidated financial statements.

 5 
 Table of Contents

WisdomTree, Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income

(In Thousands)

(Unaudited)

  

Three Months Ended

March 31,

   2025  2024
Net income  $24,629   $22,111 
Other comprehensive income/(loss)          
Foreign currency translation adjustment, net of income taxes   1,906    (359)
Other comprehensive income/(loss)   1,906    (359)
Comprehensive income  $26,535   $21,752 

The accompanying notes are an integral part of these consolidated financial statements.

 6 
 Table of Contents

WisdomTree, Inc. and Subsidiaries

Consolidated Statements of Changes in Stockholders’ Equity

(In Thousands)

(Unaudited)

   Three Months Ended March 31, 2025
  

 

Common Stock

  Additional  Accumulated
Other
      
   Shares
Issued
  Par
Value
  Paid-In
Capital
  Comprehensive
Loss
  Retained
Earnings
  Total
Balance—January 1, 2025   146,102   $1,461   $270,303   $(1,607)  $129,823   $399,980 
Restricted stock issued and vesting of restricted stock units, net   2,214    22    (22)   
    
    
 
Shares repurchased   (1,282)   (13)   (12,701)   
    
    (12,714)
Stock-based compensation       
    6,238    
    
    6,238 
Other comprehensive income       
    
    1,906    
    1,906 
Dividends       
    
    
    (4,408)   (4,408)
Net income       
    
    
    24,629    24,629 
Balance—March 31, 2025   147,034   $1,470   $263,818   $299   $150,044   $415,631 

 

 

   Three Months Ended March 31, 2024
  

 

Common Stock

  Additional  Accumulated
Other
      
   Shares
Issued
  Par
Value
  Paid-In
Capital
  Comprehensive
Loss
  Retained
Earnings
  Total
Balance—January 1, 2024   150,330   $1,503   $312,440   $(548)  $95,741   $409,136 
Restricted stock issued and vesting of restricted stock units, net   2,585    26    (26)   
    
    
 
Shares repurchased   (1,096)   (11)   (7,809)   
    
    (7,820)
Stock-based compensation       
    5,163    
    
    5,163 
Other comprehensive loss       
    
    (359)   
    (359)
Dividends       
    
    
    (4,994)   (4,994)
Net income       
    
    
    22,111    22,111 
Balance—March 31, 2024   151,819   $1,518   $309,768   $(907)  $112,858   $423,237 

The accompanying notes are an integral part of these consolidated financial statements.

 7 
 Table of Contents

WisdomTree, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(In Thousands)

(Unaudited)

  

Three Months Ended

March 31,

   2025  2024
Cash flows from operating activities:          
Net income  $24,629   $22,111 
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:          
Advisory and license fees paid in gold, other precious metals and cryptocurrency   (15,373)   (11,727)
Stock-based compensation   6,238    5,163 
Deferred income taxes   5,835    5,640 
Amortization of issuance costs—convertible notes   624    375 
Depreciation and amortization   540    383 
Imputed interest on payable to GBH   455    666 
Losses/(gains) on financial instruments owned, at fair value   440    (2,063)
Amortization of right of use asset   326    324 
Gains on investments   (316)   (123)
Changes in operating assets and liabilities:          
Accounts receivable   (394)   (4,243)
Income taxes receivable/payable   (4,092)   (2,723)
Prepaid expenses   (1,522)   (1,247)
Gold and other precious metals   14,738    11,561 
Other assets   (295)   (79)
Fund management and administration payable   3,150    2,659 
Compensation and benefits payable   (28,056)   (28,386)
Operating lease liabilities   (325)   (332)
Accounts payable and other liabilities   (232)   1,003 
Net cash provided by/(used in) operating activities   6,370    (1,038)
Cash flows from investing activities:          
Purchase of financial instruments owned, at fair value   
    (2,500)
Cash paid—software development   (577)   (592)
Purchase of fixed assets   (31)   (66)
Proceeds from the sale of financial instruments owned, at fair value   388    5,180 
Other   6    6 
Net cash (used in)/provided by investing activities   (214)   2,028 
Cash flows from financing activities:          
Common stock repurchased   (12,714)   (7,820)
Dividends paid   (4,626)   (4,997)
Excise taxes paid on common stock repurchased   (1,868)   
 
Net cash used in financing activities   (19,208)   (12,817)
Increase/(decrease) in cash flow due to changes in foreign exchange rate   2,234    (552)
Net decrease in cash, cash equivalents and restricted cash   (10,818)   (12,379)
Cash, cash equivalents and restricted cash—beginning of year   181,191    129,305 
Cash, cash equivalents and restricted cash—end of period  $170,373   $116,926 
Supplemental disclosure of cash flow information:          
Cash paid for income taxes  $4,042   $2,769 
Cash paid for interest  $6,412   $3,738 

The accompanying notes are an integral part of these consolidated financial statements.

 8 
 Table of Contents

WisdomTree, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(In Thousands, Except Share and Per Share Amounts)

1. Organization and Description of Business

WisdomTree, Inc., through its subsidiaries in the U.S. and Europe (collectively, “WisdomTree” or the “Company”), is a global financial innovator, offering a diverse suite of exchange-traded products (“ETPs”), models, solutions and products leveraging blockchain technology. Building on its heritage of innovation, the Company has introduced next-generation digital products and services, including blockchain-enabled mutual funds (“Digital Funds”) and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime, and institutional platform, WisdomTree Connect. The Company has the following wholly-owned operating subsidiaries:

WisdomTree Asset Management, Inc. is a New York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Trust (“WTT”) and WisdomTree exchange-traded funds (“ETFs”). The WisdomTree ETFs are issued in the U.S. by WTT. WTT is a non-consolidated Delaware statutory trust registered with the SEC as an open-end management investment company. The Company has licensed to WTT the use of certain of its own indexes on an exclusive basis for the WisdomTree ETFs in the U.S.
WisdomTree Management Jersey Limited (“ManJer”) is a Jersey based management company providing management services to seven issuers (the “ManJer Issuers”) in respect of the ETPs issued and listed by the ManJer Issuers covering commodity, currency, cryptocurrency and leveraged-and-inverse strategies.
WisdomTree Multi Asset Management Limited (“WTMAML”) is a Jersey based management company providing management services to WisdomTree Multi Asset Issuer PLC (“WMAI”) in respect of the ETPs issued by WMAI. WMAI is a non-consolidated public limited company domiciled in Ireland.
WisdomTree Management Limited (“WML”) is an Ireland based management company providing management services to WisdomTree Issuer ICAV (“WTICAV”) in respect of the WisdomTree UCITS ETFs issued by WTICAV. WTICAV is a non-consolidated public limited company domiciled in Ireland.
WisdomTree UK Limited (“WTUK”) is a U.K. based company registered with the Financial Conduct Authority currently providing distribution and support services to ManJer, WTMAML and WML.
WisdomTree Europe Limited is a U.K. based company which is the legacy distributor of the WMAI ETPs and WisdomTree UCITS ETFs. These services are now provided directly by WTUK. WisdomTree Europe Limited is no longer regulated and does not provide any regulated services.
WisdomTree Ireland Limited (“WT Ireland”) is an Ireland based company authorized by the Central Bank of Ireland providing distribution services to ManJer, WTMAML and WML.
WisdomTree Digital Commodity Services, LLC is a New York based company that serves as the sponsor of the WisdomTree Bitcoin Fund, which is currently effective with the SEC. The WisdomTree Bitcoin Fund is an exchange-traded fund that issues common shares of beneficial interest and is listed on the Cboe BZX Exchange, Inc. The WisdomTree Bitcoin Fund provides exposure to the spot price of bitcoin.
WisdomTree Digital Management, Inc. (“WT Digital Management”) is a New York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Digital Trust (“WTDT”) and WisdomTree Digital Funds. The WisdomTree Digital Funds are issued in the U.S. by WTDT. WTDT is a non-consolidated Delaware statutory trust registered with the SEC as an open-end management investment company. Each Digital Fund uses a blockchain-integrated recordkeeping system to maintain a record of its shares on one or more blockchains (e.g., Stellar or Ethereum), but does not directly or indirectly invest in any assets that rely on blockchain technology, such as cryptocurrencies.
WisdomTree Digital Movement, Inc. (“WT Digital Movement”) is a New York based company operating as a money services business registered with the Financial Crimes Enforcement Network. WT Digital Movement has obtained and is seeking additional state money transmitter licenses to operate a platform for the purchase, sale and exchange of tokenized assets, while also providing blockchain-native digital wallet services through WisdomTree Prime to facilitate such activity.
WisdomTree Securities, Inc. is a New York based limited purpose broker-dealer (i.e., mutual fund retailer) registered with the SEC and FINRA, facilitating transactions in WisdomTree Digital Funds.
WisdomTree Transfers, Inc. is a New York based transfer agent registered with the SEC, providing transfer agency and registrar services for the Digital Funds. The transfer agent uses a blockchain-integrated recordkeeping system for the ownership of WisdomTree Digital Fund shares.
WisdomTree Digital Trust Company, LLC is a New York based limited liability trust company that has been formed to operate as a limited purpose trust company under New York Banking Law and is licensed to engage in virtual currency business activity by the New York State Department of Financial Services.

 9 
 Table of Contents

2. Significant Accounting Policies

Basis of Presentation

These consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the financial statements. The consolidated financial statements include the accounts of the Company’s wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Consolidation

The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (“VOE”) or a variable interest entity (“VIE”). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur.

Segment and Geographic Information

The Company, through its subsidiaries in the U.S. and Europe, is a global financial innovator, offering a diverse suite of ETPs, models, solutions and products leveraging blockchain technology. The Company conducts business as a single operating segment as an ETP sponsor and asset manager, which is based upon the Company’s current organizational and management structure, as well as information used by the Company’s Chief Executive Officer (the chief operating decision maker, or CODM) to allocate resources and other factors.

Foreign Currency Translation

Assets and liabilities of subsidiaries whose functional currency is not the U.S. dollar are translated based on the end of period exchange rates from local currency to U.S. dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income as a component of other comprehensive (loss)/income.

Use of Estimates

The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates.

Revenue Recognition

The Company earns a significant portion of its revenues in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs’ average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.

Other revenues are earned from swap providers associated with certain of the Company’s European listed ETPs, the nature of which are based on a percentage of the ETPs’ average daily net assets. The Company also earns transaction-based income on flows associated with certain European listed ETPs. There is no significant judgment in calculating amounts due, which are invoiced monthly or quarterly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.

Marketing and Advertising

Marketing and advertising costs, including media advertising and production costs, are expensed when incurred.

 10 
 Table of Contents

Depreciation and Amortization

Depreciation and amortization is provided for using the straight-line method over the estimated useful lives of the related assets as follows:

Equipment  3 to 5 years
Internally-developed software  3 years

The assets listed above are recorded at cost, less accumulated depreciation and amortization.

Stock-Based Awards

Accounting for stock-based compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock-based compensation is measured based on the grant-date fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur.

Third-Party Distribution Fees

The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (“AUM”), subject to caps or minimums, to marketing agents to sell WisdomTree ETPs and for including WisdomTree ETPs on third-party customer platforms and recognizes these expenses as incurred.

Cash, Cash Equivalents and Restricted Cash

The Company considers all highly liquid investments with an original maturity of 90 days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits. Restricted cash is required to be maintained in a separate account with withdrawal and usage restrictions.

Accounts Receivable

Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method.

Financial Instruments Owned

Financial instruments owned are financial instruments classified as either trading or available-for-sale (“AFS”). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company’s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit-related impairments are recognized in earnings with a corresponding adjustment to the instrument’s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit-related impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit-related factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method.

Investments

The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (“ASC”) Topic 321, Investments – Equity Securities (“ASC 321”), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.

Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).

Goodwill

Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring re-evaluation, if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.

 11 
 Table of Contents

Goodwill is allocated to the Company’s U.S. and European components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.

Goodwill is assessed for impairment annually on November 30th. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit.

Intangible Assets

Indefinite-lived intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their estimated fair values are less than their carrying values.

Finite-lived intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite-lived intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.

The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company’s intangible assets is November 30th.

Software Development Costs

Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight-line basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred.

Leases

The Company accounts for its lease obligations in accordance with ASC Topic 842, Leases (“ASC 842”), which requires the recognition of both (i) a lease liability equal to the present value of the remaining lease payments and (ii) an offsetting right-of-use asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company’s incremental borrowing rate. After lease commencement, right-of-use assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight-line basis. These recognition requirements are not applied to short-term leases, which are those with a lease term of 12 months or less. Instead, lease payments associated with short-term leases are recognized as an expense on a straight-line basis over the lease term.

ASC 842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and non-lease components. The Company has elected to apply this practical expedient to all lease contracts, where applicable.

Convertible Notes

Convertible notes are carried at amortized cost, net of issuance costs. The Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt.

Contingencies

The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable.

Contingent Payments

The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized.

 12 
 Table of Contents

Earnings per Share

Basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the two-class method. Share-based payment awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).

Diluted EPS is calculated under the treasury stock method and the two-class method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company’s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock-based awards and the convertible notes, if any. Potential common shares associated with the convertible notes are computed under the if-converted method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company’s average stock price exceeds the conversion price.

Income Taxes

The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not that some portion or all the deferred tax assets will not be realized.

Tax positions are evaluated utilizing a two-step process. The Company first determines whether any of its tax positions are more-likely-than-not to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense.

The Global Intangible Low-Taxed Income (“GILTI”) provisions of the Tax Reform Act requires the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax.

Non-income based taxes are recorded as part of other liabilities and other expenses. Excise taxes on stock repurchases are accounted for as a direct component of the share repurchase transaction and reported as a reduction of stockholder’s equity.

Recently Issued Accounting Pronouncements

On November 4, 2024, the Financial Accounting Standards Board (“FASB”) issued ASU 2024-03, Reporting Comprehensive Income—Expense Disaggregation Disclosures, which requires additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods. The guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company does not anticipate this standard to have a material impact on its financial statements.

Recently Adopted Accounting Pronouncements

On December 14, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Improvements to Income Tax Disclosures, which establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing requirements. Under the new guidance, entities must consistently categorize and provide greater disaggregation of information in the rate reconciliation. They must also further disaggregate income taxes paid. The standard is intended to benefit stockholders by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The guidance applies to all entities subject to income taxes and is effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company adopted this standard on a prospective basis for the year ended December 31, 2024. See Note 18 for additional information.

3. Cash, Cash Equivalents and Restricted Cash

Of the total cash, cash equivalents and restricted cash of $170,373 and $181,191 at March 31, 2025 and December 31, 2024, respectively, $156,726 and $155,871 were held at three financial institutions. At March 31, 2025 and December 31, 2024, cash equivalents were approximately $90,896 and $48,336, respectively.

Certain of the Company’s subsidiaries are required to maintain a minimum level of regulatory capital, generally satisfied by cash on hand, which was $35,580 and $39,423 at March 31, 2025 and December 31, 2024, respectively. Of these amounts, $13,499 and $13,403, at March 31, 2025 and December 31, 2024, respectively, was restricted cash, which is required to be maintained in a separate account with withdrawal and usage restrictions in compliance with regulatory obligations.

 13 
 Table of Contents

4. Fair Value Measurements

The fair value of financial instruments is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., “the exit price”) in an orderly transaction between market participants at the measurement date. ASC 820, Fair Value Measurement, establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs reflect assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the transparency of inputs as follows:

Level 1 – Quoted prices for identical instruments in active markets.

Level 2 – Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

Level 3 – Instruments whose significant drivers are unobservable.

The availability of observable inputs can vary from product to product and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level 3. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

The tables below summarize the categorization of the Company’s assets and liabilities measured at fair value. During the three months ended March 31, 2025 and 2024, there were no transfers between Levels 2 and 3.

   March 31, 2025
   Total  Level 1  Level 2  Level 3
Assets:            
Recurring fair value measurements:                    
Cash equivalents  $90,896   $90,896   $
   $
 
Financial instruments owned, at fair value:                    
ETFs   62,974    62,974    
    
 
Pass-through GSEs   6,704    
    6,704    
 
Other assets—seed capital (WisdomTree Digital Funds):                    
U.S. treasuries   5,647    
    5,647    
 
Equities   8,023    8,023    
    
 
Fixed income   1,946    1,025    921    
 
Other investments   755    
    
    755 
Total  $176,945   $162,918   $13,272   $755 

 14 
 Table of Contents

   December 31, 2024
   Total  Level 1  Level 2  Level 3
Assets:            
Recurring fair value measurements:                    
Cash equivalents  $48,336   $48,336   $
   $
 
Financial instruments owned, at fair value:                    
ETFs   62,907    62,907    
    
 
Pass-through GSEs   6,898    
    6,898    
 
Other assets—seed capital (WisdomTree Digital Funds):                    
U.S. treasuries   5,251    
    5,251    
 
 
Equities   8,478    8,478    
    
 
Fixed income   1,905    1,019    886    
 
Other investments   687    
    
    687 
Total  $134,462   $120,740   $13,035   $687 
                     
Non-recurring fair value measurements:                    
Fnality International Limited—Series B-1 Preference Shares(1)  $8,288   $
   $
   $8,288 

_____________________________

(1)Fair value determined on June 17, 2024. Not included above are prospective changes in value due to fluctuations in the British pound to U.S. dollar exchange rate.

Recurring Fair Value Measurements – Methodology

Cash Equivalents (Note 3) – These financial assets represent cash invested in highly liquid investments with original maturities of less than 90 days. These investments are valued at par, which approximates fair value, and are classified as Level 1 in the fair value hierarchy.

Financial instruments owned (Note 5) – Financial instruments owned are investments in ETFs, pass-through GSEs, equities and fixed income. ETFs and equities are generally traded in active, quoted and highly liquid markets and are therefore classified as Level 1 in the fair value hierarchy. Pricing of pass-through GSEs and fixed income includes consideration given to date of issuance, collateral characteristics and market assumptions related to yields, credit risk and timing of prepayments and may be classified as either Level 1 or Level 2.

Fair Value Measurements classified as Level 3 – The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3:

These instruments consist of the following:

   Three Months Ended
  

March 31,
2025

 

March 31,
2024

Other Investments:          
Beginning balance  $687   $
 
Net unrealized gains(1)   68    
 
Ending balance  $755   $
 

_____________________________

(1)Recorded in other losses and gains, net in the Consolidated Statements of Operations.

 15 
 Table of Contents

5. Financial instruments owned

These instruments consist of the following:

  

March 31,
2025

 

December 31,
2024

Financial instruments owned          
Trading securities  $69,678   $69,805 
Other assets—seed capital (WisdomTree Digital Funds)   15,616    15,634 
Total  $85,294   $85,439 

The Company recognized net trading gains on financial instruments owned that were still held at the reporting dates of $545 and $1,904 during the three months ended March 31, 2025 and 2024, respectively, which were recorded in other losses and gains, net, in the Consolidated Statements of Operations.

6. Investments

The following is a summary of the Company’s investments:

   March 31, 2025  December 31, 2024
   Carrying Value  Cost  Carrying Value  Cost
             
Fnality International Limited—Series B-1 Preference Shares  $8,482   $8,091   $8,235   $8,091 
Other investments   755    674    687    674 
Total  $9,237   $8,765   $8,922   $8,765 

Fnality International Limited

The Company owns approximately 5.4% (or 4.7% on a fully-diluted basis) of capital stock of Fnality International Limited (“Fnality”), a company incorporated in England and Wales and focused on creating a peer-to-peer digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross-border payments from a single pool of liquidity. The Company’s ownership interest is represented by 2,340,378 Series B-1 Preference Shares, resulting from the conversion of its investment of £6,000 ($8,091) in convertible notes upon Fnality’s qualified equity financing which occurred in October 2023. The Series B-1 Preference Shares carry a 1.0x liquidation preference, are convertible into ordinary shares at the option of the Company and contain various rights and protections.

This investment is accounted for under the measurement alternative prescribed in ASC 321, as it does not have a readily determinable fair value and is otherwise not subject to the equity method of accounting. The investment is assessed for impairment and similar observable transactions on a quarterly basis. This investment was re-measured to fair value upon the conversion of Fnality’s Series B-2 Preference Shares held by other investors into Series B-1 Preference Shares, which occurred in June 2024. Fair value was determined using the backsolve method, a valuation approach that determines the value of shares for companies with complex capital structures based upon the price paid for shares recently issued. Fair value was allocated across the capital structure using the Black-Scholes option pricing model. The table below presents the inputs used in the backsolve valuation approach (classified as Level 3 in the fair value hierarchy):

   Inputs
  

June 17,

2024

Expected volatility   60%
Time to exit (in years)   4.35 
Probability that Series B-2 Preference Shares convert into Series B-1 Preference Shares   
  N/A
 

Net unrealized gains/(losses) recognized on this investment were $247 and ($78) during the three months ended March 31, 2025 and 2024, respectively, inclusive of changes in the British pound to U.S. dollar exchange rate. These results are recorded in other losses and gains, net on the Consolidated Statements of Operations.

There was no impairment recognized on this investment during the three months ended March 31, 2025 based upon a qualitative assessment.

Other Investments

On October 2, 2024, the Company purchased an investment of $674. During the three months ended March 31, 2025, the Company recognized an unrealized gain of $68, recorded in other losses and gains, net in the Consolidated Statements of Operations.

 16 
 Table of Contents

7. Fixed Assets, Net

The following table summarizes fixed assets:

  

March 31,

2025

 

December 31,

2024

Equipment  $1,100   $1,069 
Less: accumulated depreciation   (798)   (733)
Total  $302   $336 

8. Convertible Notes

The Company has the following convertible notes outstanding as of March 31, 2025:

$150,000 in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the “2026 Notes”);
$25,845 in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the “2028 Notes”); and
$345,000 in aggregate principal amount of 3.25% Convertible Senior Notes due 2029 (the “2029 Notes”).

Each class of notes were issued pursuant to indentures dated as of the issuance dates between the Company and U.S Bank Trust Company, National Association, as trustee (either initially or as successor to U.S. Bank National Association, the “Trustee”), in private offerings to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

As of March 31, 2025, the Company had an aggregate principal amount of $520,845 outstanding of the 2026 Notes, the 2028 Notes and the 2029 Notes (collectively, the “Convertible Notes”).

Key terms of the Convertible Notes are as follows:

   2026 Notes  2028 Notes  2029 Notes
Principal outstanding  $150,000   $25,845   $345,000 
Issuance date  June 14, 2021   February 14, 2023   August 13, 2024 
Maturity date (unless earlier converted, repurchased or redeemed)  June 15, 2026   August 15, 2028   August 15, 2029 
Interest rate  3.25%  5.75%  3.25%
Initial conversion price  $11.04   $9.54   $11.82 
Initial conversion rate  90.5797   104.8658   84.5934 
Redemption price  $14.35   $12.40   $15.37 
Interest rate: Payable semiannually in arrears on February 15 and August 15 of each year for the 2029 Notes and the 2028 Notes and on June 15 and December 15 of each year for the 2026 Notes.
Conversion price: Convertible at an initial conversion rate into shares of the Company’s common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.
Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2029 and May 15, 2028 for the 2029 Notes and the 2028 Notes, respectively, and March 15, 2026 for the 2026 Notes, only under the following circumstances: (i) if the last reported sale price of the Company’s common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company’s common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2029 and May 15, 2028 in respect of the 2029 Notes and the 2028 Notes, respectively, and March 15, 2026 in respect of the 2026 Notes, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.
Cash settlement of principal amount: Upon conversion, the Company will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At its election, the Company will also settle the conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of its common stock or a combination of cash and shares of its common stock.

 17 
 Table of Contents

Redemption price: The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August 20, 2026 and August 20, 2025 in respect of the 2029 Notes and the 2028 Notes, respectively, and June 20, 2023 in respect of the 2026 Notes and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the respective Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.
Limited investor put rights: Holders of the Convertible Notes have the right to require the Company to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.
Conversion rate increase in certain customary circumstances: In certain circumstances, conversions in connection with a “make-whole fundamental change” (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 103.6269 shares, 167.7853 shares and 144.9275 shares of the Company’s common stock per $1,000 principal amount of the 2029 Notes, the 2028 Notes and the 2026 Notes, respectively (the equivalent of 61,826,817 shares of the Company’s common stock based on the aggregate principal amount of Convertible Notes outstanding), subject to adjustment.
Seniority and Security: The Convertible Notes rank equal in right of payment and are the Company’s senior unsecured obligations.

The indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the respective holders of not less than 25% in aggregate principal amount of the respective series of Convertible Notes outstanding may declare the entire principal amount of all such respective Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.

The following table provides a summary of the Convertible Notes at March 31, 2025 and December 31, 2024:

   March 31, 2025  December 31, 2024
   2026 Notes  2028 Notes  2029 Notes  Total  2026 Notes  2028 Notes  2029 Notes  Total
Principal amount  $150,000   $25,845   $345,000   $520,845   $150,000   $25,845   $345,000   $520,845 
Less: Unamortized issuance costs   (1,047)   (435)   (6,706)   (8,188)   (1,263)   (466)   (7,083)   (8,812)
Carrying amount  $148,953   $25,410   $338,294   $512,657   $148,737   $25,379   $337,917   $512,033 
Effective interest rate(1)   3.83%   6.25%   3.70%   3.86%   3.83%   6.25%   3.70%   3.86%

_____________________________

(1)Includes amortization of the issuance costs and premium.

Interest expense on the Convertible Notes during the three months ended March 31, 2025 and 2024 was $4,986 and $3,462, respectively. Interest payable of $3,058 and $5,107 at March 31, 2025 and December 31, 2024, respectively, is included in accounts payable and other liabilities on the Consolidated Balance Sheets.

The fair value of the Convertible Notes (classified as Level 2 in the fair value hierarchy) was $531,340 and $571,031 at March 31, 2025 and December 31, 2024, respectively. The if-converted value of the Convertible Notes did not exceed the principal amount at March 31, 2025. The if-converted value of the 2028 Notes was $28,446 at December 31, 2024. The if-converted value of the 2026 Notes and the 2029 Notes did not exceed the principal amount at December 31, 2024.

9. Payable to Gold Bullion Holdings (Jersey) Limited (“GBH”)

On November 20, 2023, the Company repurchased all of its then-outstanding Series C Non-Voting Convertible Preferred Stock, par value $0.01 per share (the “Series C Preferred Stock”) which was convertible into 13,087,000 shares of the Company’s common stock, from GBH, a subsidiary of the World Gold Council, for aggregate cash consideration of approximately $84,411. Under the terms of the transaction, the Company has paid GBH $54.8 million to date, with the remainder of the purchase price payable in equal, interest-free installments on the second and third anniversaries of the closing date. The implied price per share was $6.02 when considering the interest-free financing element of the transaction. The investor rights agreement that the Company and GBH entered into in May 2023 in connection with the issuance of the Series C Preferred Stock, which provided GBH with certain rights and obligations with respect to the shares, including registration rights, was terminated in this transaction.

 18 
 Table of Contents

Under U.S. GAAP, the obligation was recorded at its present value utilizing a market rate of interest on the closing date of 7.0% and the corresponding discount is being amortized as interest expense pursuant to the effective interest method of accounting over the life of the obligation. The aggregate consideration payable was valued at $38,835 on the closing date and the carrying value of this obligation is as follows:

  

March 31,

2025

 

December 31,

2024

Current:   $14,804   $14,804 
Long-term    12,615    12,159 
Total   $27,419   $26,963 

Interest expense recognized during the three months ended March 31, 2025 and 2024 was $455 and $666, respectively, and is included as a component of total interest expense recognized on the Consolidated Statements of Operations.

10. Leases

The Company has entered into operating leases for its office facilities (including its corporate headquarters) and equipment. The Company has no finance leases.

The following table provides additional information regarding the Company’s leases:

  

Three Months Ended

March 31,

   2025  2024
Lease cost          
Operating lease cost  $326   $324 
Short-term lease cost   52    93 
Total lease cost  $378   $417 
Other information          
Cash paid for amounts included in the measurement of operating liabilities (operating leases)  $325   $332 
Right-of-use assets obtained in exchange for new operating lease liabilities   

n/a

    

n/a

 
Weighted-average remaining lease term (in years)operating leases   1.0    0.2 
Weighted-average discount rateoperating leases   9.5%   5.8%

None of the Company’s leases include variable payments, residual value guarantees or any restrictions or covenants relating to the Company’s ability to pay dividends or incur additional financing obligations.

The following table discloses future minimum lease payments at March 31, 2025 with respect to the Company’s operating lease liabilities:

Remainder of 2025  $429         
2026   180         
2027 and thereafter   
         
Total future minimum lease payments (undiscounted)  $609         

The following table reconciles the future minimum lease payments (disclosed above) at March 31, 2025 to the operating lease liabilities recognized in the Company’s Consolidated Balance Sheets:

Amounts recognized in the Company’s Consolidated Balance Sheets           
Lease liability—short term  $493         
Lease liability—long term   89         
Subtotal   582         
Difference between undiscounted and discounted cash flows   27         
Total future minimum lease payments (undiscounted)  $609         

11. Contingencies

The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business.

 19 
 Table of Contents

Closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP

Between December 2020 and December 2024, WMAI, WTMAML, WTUK and/or WT Ireland were served with eight separate writs of summons to appear before the Courts of Milan, Udine or Turin, Italy by investors seeking damages resulting from the closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP (“3OIL”) in March 2020. The product was dependent on the receipt of payments from a swap provider to satisfy payment obligations to the investors. Due to an extreme adverse move in oil futures relative to the oil futures’ closing price, the swap contract underlying 3OIL was terminated by the swap provider, which resulted in the compulsory redemption of 3OIL, all in accordance with the prospectus.

Since February 2022, six of the eight actions have been resolved in the Company’s favor, of which three have been appealed. Total damages sought by all investors related to the remaining open and appealed claims were approximately €17,850 ($19,330) at March 31, 2025, of which €15,240 ($16,510) relates to three appealed claims.

Additionally, in July 2023, WT Ireland received a letter from counsel on behalf of additional investors seeking damages of up to approximately €8,350 ($9,040) resulting from the closure of 3OIL. The claim is in its preliminary stages and a writ of summons has not been served.

The Company continues to assess the open and appealed claims with its external counsel. The Company expects that losses, if any, arising from these claims will be covered under its insurance policies, less a $500 deductible. An accrual has not been made with respect to these matters at March 31, 2025 and December 31, 2024.

12. Variable Interest Entities

VIEs are entities with any of the following characteristics: (i) the entity does not have enough equity to finance its activities without additional financial support; (ii) the equity holders, as a group, lack the characteristics of a controlling financial interest; or (iii) the entity is structured with non-substantive voting rights.

Consolidation of a VIE is required for the party deemed to be the primary beneficiary, if any. The primary beneficiary is the party who has both (a) the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. The Company is not the primary beneficiary of any entities in which it has a variable interest as it does not have the power to direct the activities that most significantly impact the entities’ economic performance. Such power is conveyed through the entities’ boards of directors and the Company does not have control over the boards.

The following table presents information about the Company’s variable interests in non-consolidated VIEs:

  

March 31,

2025

 

December 31,

2024

Carrying AmountAssets:          
Fnality Series B-1 Preference Shares (Note 6)  $8,482   $8,235 
Other investments   755    687 
Total  $9,237   $8,922 
Maximum exposure to loss  $9,237   $8,922 

13. Revenues from Contracts with Customers

The following table presents the Company’s total revenues from contracts with customers:

  

Three Months Ended

March 31,

   2025  2024
Revenues from contracts with customers:          
Advisory fees  $99,549   $92,501 
Other   8,533    4,337 
Total operating revenues  $108,082   $96,838 

The Company recognizes revenues from contracts with customers when the performance obligation is satisfied, which is when the promised services are transferred to the customer. A service is considered to be transferred when the customer obtains control, which is represented by the transfer of rights with regard to the service. Transfer of control happens either over time or at a point in time. When a performance obligation is satisfied over time, an entity is required to select a single method of measuring progress for each performance obligation that depicts the entity’s performance in transferring control of services to the customer.

 20 
 Table of Contents

A significant portion of the Company’s revenues from contracts with customers is derived primarily from investment advisory agreements with related parties (Note 14). These advisory fees are recognized over time, are earned from the Company’s ETPs and are calculated based on a percentage of the ETPs’ average daily net assets. There is no significant judgment in calculating amounts due which are invoiced monthly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.

There are no contract assets or liabilities that arise in connection with the recognition of advisory fee revenue. In addition, there are no costs incurred to obtain or fulfill the contracts with customers, all of which are investment advisory agreements with related parties.

Other revenues include revenues the Company earns from swap providers associated with certain of the Company’s European listed ETPs, the nature of which are based on a percentage of the ETPs’ average daily net assets. The Company also earns transaction-based income on flows associated with certain European listed ETPs. There is no significant judgment in calculating amounts due, which are invoiced monthly or quarterly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.

Geographic Distribution of Revenues

The following table presents the Company’s total revenues geographically as determined by where the respective management companies reside:

  

Three Months Ended

March 31,

   2025  2024
Revenues from contracts with customers:          
United States  $69,469   $65,830 
Jersey   32,593    26,094 
Ireland   6,020    4,914 
Total operating revenues  $108,082   $96,838 

14. Related Party Transactions

Investment Advisory Agreements

The Company’s revenues are derived primarily from investment advisory agreements with related parties. Under these agreements, the Company has licensed to related parties the use of certain of its own indexes for the U.S. WisdomTree ETFs, WisdomTree Digital Funds and WisdomTree UCITS ETFs. The relevant boards of trustees or boards of directors (including certain officers of the Company) of each of the related parties is primarily responsible for overseeing the management and affairs of the entities for the benefit of their respective stakeholders and have contracted with the Company to provide for general management and administration services. The Company is also responsible for certain expenses of the related parties, including the cost of transfer agency, custody, fund administration and accounting, legal, audit, and other non-distribution services, excluding extraordinary expenses, taxes and certain other expenses, which are included in fund management and administration in the Consolidated Statements of Operations. In exchange, the Company receives fees based on a percentage of the ETPs’ and the Digital Funds’ average daily net assets. A majority of the independent members of the respective board of trustees or board of directors are required to initially and annually (after the first two years) approve the advisory agreements of the U.S. WisdomTree ETFs and the WisdomTree Digital Funds and these agreements may be terminated by such board of trustees or board of directors upon notice.

The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets:

  

March 31,

2025

  December 31,
2024
Receivable from WTT  $24,101   $24,672 
Receivable from ManJer Issuers   6,100    5,155 
Receivable from WMAI and WTICAV   5,239    5,132 
Total  $35,440   $34,959 

The allowance for credit losses on accounts receivable from related parties is insignificant when applying historical loss rates, adjusted for current conditions and supportable forecasts, to the amounts outstanding in the table above. Amounts outstanding are all invoiced in arrears, are less than 30 days aged and are collected shortly after the applicable reporting period.

 21 
 Table of Contents

The following table summarizes revenues from advisory services provided to related parties:

  

Three Months Ended

March 31,

   2025  2024
Advisory services provided to WTT  $68,855   $64,902 
Advisory services provided to ManJer Issuers   24,674    22,685 
Advisory services provided to WMAI and WTICAV   6,020    4,914 
Total  $99,549   $92,501 

Investments in WisdomTree Products

The Company also has investments in certain WisdomTree products of $89,872 and $89,822 at March 31, 2025 and December 31, 2024, respectively. This includes $20,848 and $20,866, respectively, of seed investments in certain consolidated affiliated Digital Funds advised by WT Digital Management, referred to herein as “other assets–seed capital.” As of March 31, 2025, the Company has also invested an additional $6,050 in the WisdomTree Government Money Market Digital Fund.

Net unrealized and realized gains related to trading WisdomTree products were $647 and $1,945, respectively, during the three months ended March 31, 2025 and 2024. Such gains are recorded in other losses and gains, net on the Consolidated Statements of Operations.

15. Stock-Based Awards

On July 15, 2022, the Company’s stockholders approved the 2022 Equity Plan under which the Company may issue up to 16,000,000 shares of common stock (less one share for every share granted under the 2016 Equity Plan since March 31, 2022 and inclusive of shares available under the 2016 Equity Plan as of March 31, 2022) in the form of stock options and other stock-based awards.

The Company grants equity awards to employees and directors, which include restricted stock awards (“RSAs”), restricted stock units (“RSUs”), including deferred RSUs to non-employee directors, performance-based restricted stock units (“PRSUs”) and stock options. Certain awards described below are subject to acceleration under certain conditions.

 Stock options:Generally issued for terms of ten years and may vest after at least one year of service and have an exercise price equal to the Company’s stock price on the grant date. The Company estimates the fair value of stock options (when granted) using the Black-Scholes option pricing model.
   
RSAs/RSUs:Awards are valued based on the Company’s stock price on grant date and generally vest ratably, on an annual basis, over three years. For non-employee directors, such awards generally vest on the one-year anniversary of the grant date.
   
 Deferred RSUs:

Awards are valued based on the Company’s stock price on grant date and generally vest on the one-year anniversary of the grant date. The awards are issued pursuant to the Company’s Non-Employee Director Deferred Compensation Program and are settled based on timing elected by the recipient in advance.

   
 PRSUs:These awards cliff vest three years from the grant date and contain a market condition whereby the number of PRSUs ultimately vesting is tied to how the Company’s total shareholder return (“TSR”) compares to a peer group of other publicly traded asset managers over the three-year period. A Monte Carlo simulation is used to value these awards.

The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:

     If the relative TSR is below the 25th percentile, then 0% of the target number of PRSUs granted will vest;

     If the relative TSR is at the 25th percentile, then 50% of the target number of PRSUs granted will vest;

     If the relative TSR is above the 25th percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50th percentile and capped at 200% of the target number of PRSUs granted for performance at the 85th percentile; and

     If the Company’s TSR is negative, the target number of PRSUs vesting is capped at 100% regardless of the relative TSR percentile.

Stock-based compensation expense was $6,238 and $5,163, respectively, during the three months ended March 31, 2025 and 2024.

 22 
 Table of Contents

A summary of unrecognized stock-based compensation expense and average remaining vesting period is as follows:

   March 31, 2025
  

Unrecognized 

Stock-Based
Compensation

 

Weighted-Average

Remaining Vesting 

Period (Years)

Employees and directors  $31,183    1.39 

 

A summary of stock-based compensation award activity (shares) during the three months ended March 31, 2025 is as follows:

   RSA  RSU  PRSU
Balance at January 1, 2025   4,827,044    268,084    1,406,560 
Granted   1,518,667    66,047    344,350(1)
Vested   (2,352,511)   (47,603)   
(337,625
)(2)
Forfeited   (27,156)   
    
 
Stock dividends accrued   
    441    3,286 
Balance at March 31, 2025   3,966,044    286,969(3)   1,416,571 

_____________________________

(1)Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. A Monte-Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning 90-day average stock prices; (ii) valuation date stock prices; (iii) historical stock price volatilities ranging from 24.47% to 36.61% (average 31.38%); (iv) correlation coefficients based upon the price data used to calculate the historical volatilities; (v) a risk free interest rate of 4.28%; and (vi) an expected dividend yield of 0.00%.
(2)The payout on PRSUs vesting in January 2025 was 200%.
(3)Includes 103,829 deferred RSUs that have vested.

16. Stockholder Rights Plan

On March 17, 2023, the Board of Directors of the Company adopted a stockholder rights plan, as set forth in the Stockholder Rights Agreement, dated March 17, 2023, between the Company and Continental Stock Transfer & Trust Company, as Rights Agent, as amended by Amendment No. 1 thereto, dated May 4, 2023 (“Amendment No. 1”), Amendment No. 2 thereto, dated May 10, 2023 (“Amendment No. 2”), Amendment No. 3 thereto, dated March 18, 2024 (“Amendment No. 3”), Amendment No. 4 thereto, dated March 25, 2024 (“Amendment No. 4”), and Amendment No. 5 thereto, dated April 30, 2024 (“Amendment No. 5”) (as amended, the “Stockholder Rights Agreement”). On March 18, 2024, the Company entered into Amendment No. 3, which extended the expiration date of the Stockholder Rights Agreement to the close of business on March 17, 2025. At the Company’s 2024 annual meeting of stockholders on June 12, 2024, the Company’s stockholders ratified the adoption by the Board of Directors of the extension of the Stockholder Rights Agreement.

On March 17, 2025, the Stockholder Rights Agreement expired by its terms and the associated preferred stock purchase rights to purchase shares of Series B Junior Participating Cumulative Preferred Stock of the Company (the “Series B Preferred Stock”) expired. Following the expiration of the Stockholder Rights Agreement, on March 18, 2025, the Company filed a Certificate of Elimination to its Amended and Restated Certificate of Incorporation, as amended (the “Charter”), with the Secretary of State of the State of Delaware, eliminating from the Charter all references to the Series B Preferred Stock set forth in the Company’s Certificate of Designations with respect to its Series B Preferred Stock. No shares of Series B Preferred Stock were outstanding at the time the Certificate of Elimination was filed. The Certificate of Elimination became effective on March 18, 2025.

 23 
 Table of Contents

17. Earnings Per Share

The following tables set forth reconciliations of the basic and diluted earnings per share computations for the periods presented:

  

Three Months Ended
March 31,

Basic Earnings per Share  2025  2024
Net income  $24,629   $22,111 
Less:  Income distributed to participating securities   
    (462)
Less:  Undistributed income allocable to participating securities   (24)   (1,657)
Net income available to common stockholdersBasic EPS  $24,605   $19,992 
Weighted average common shares (in thousands)   142,580    146,464 
Basic earnings per share  $0.17   $0.14 
  

Three Months Ended
March 31,

Diluted Earnings per Share  2025  2024
Net income available to common stockholders  $24,605   $19,992 
Add back:  Undistributed income allocable to participating securities   24    1,657 
Less:  Reallocation of undistributed income allocable to participating securities considered potentially dilutive   (23)   (1,622)
Net income available to common stockholdersDiluted EPS  $24,606   $20,027 
Weighted average diluted shares (in thousands):          
Weighted average common shares   142,580    146,464 
Dilutive effect of common stock equivalents, excluding participating securities   3,799    3,525 
Weighted average diluted shares, excluding participating securities (in thousands)   146,379    149,989 
Diluted earnings per share  $0.17   $0.13 

Diluted earnings per share presented above is calculated using the two-class method as this method results in the lowest diluted earnings per share amount for common stock. Total antidilutive non-participating common stock equivalents were 1,025 for the three months ended March 31, 2025 (shares herein are reported in thousands). There were no antidilutive non-participating common stock equivalents for the three months ended March 31, 2024.

There were no potential common shares associated with the conversion options embedded in the Convertible Notes included in weighted average diluted shares for the three months ended March 31, 2025 and 2024 as the Company’s average stock price was lower than the conversion price.

The following table reconciles weighted average diluted shares as reported on the Company’s Consolidated Statements of Operations for the three months ended March 31, 2025 and 2024, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings per share as disclosed in the table above:

  

Three Months Ended

March 31,

Reconciliation of Weighted Average Diluted Shares (in thousands)  2025  2024
Weighted average diluted shares as disclosed on the Consolidated Statements of Operations   146,545    165,268 
Less:  Participating securities:          
Weighted average shares of common stock issuable upon conversion of the Series A Preferred Stock   
    (14,750)
Potentially dilutive restricted stock awards   (166)   (529)
Weighted average diluted shares used to calculate diluted earnings per share as disclosed in the table above   146,379    149,989 

18. Income Taxes

Effective Income Tax Rate – Three Months Ended March 31, 2025

The Company’s effective income tax rate during the three months ended March 31, 2025 was 18.9%, resulting in income tax expense of $5,739. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due to tax windfalls associated with the vesting of stock-based compensation awards and a lower tax rate on foreign earnings. These items were partly offset by state and local income taxes.

 24 
 Table of Contents

Effective Income Tax Rate – Three Months Ended March 31, 2024

The Company’s effective income tax rate during the three months ended March 31, 2024 was 20.5%, resulting in income tax expense of $5,701. The effective income tax rate differs from the federal statutory tax rate of 21% primarily due to the decrease in the deferred tax asset valuation allowance on losses recognized on the Company’s financial instruments owned, tax windfalls associated with the vesting of stock-based compensation awards and a lower tax rate on foreign earnings. These items were partly offset by state and local income taxes.

Income Tax Payments

Disclosed below is a summary of income taxes paid by jurisdiction pursuant to the disclosure requirements of ASU 2023-09 for the three months ended March 31, 2025:

  

Three Months
March 31, 2025

United States - Federal  $
 
United States - State and local   204 
United Kingdom   3,829 
Other   9 
   $4,042 

Deferred Tax Assets

A summary of the components of the Company’s deferred tax assets at March 31, 2025 and December 31, 2024 is as follows:

  March 31,
2025
  December 31,
2024
Deferred tax assets:          
Capital losses  $18,563   $21,984 
Accrued expenses   1,559    6,465 
Stock-based compensation   1,019    2,843 
NOLs—Foreign   998    1,024 
Interest carryforward.   856    
 
Goodwill and intangible assets   657    705 
Software capitalization   244    199 
Foreign currency translation adjustment   173    427 
Operating lease liabilities   38    95 
Other   326    331 
Deferred tax assets   24,433    34,073 
           
           
Deferred tax liabilities:          
Unremitted earnings—European subsidiaries   109    92 
Fixed assets and prepaid assets   101    246 
Unrealized gains   87    76 
Right of use assets—operating leases   38    95 
Deferred tax liabilities   335    509 
Total deferred tax assets less deferred tax liabilities   24,098    33,564 
Less: Valuation allowance   (18,476)   (21,908)
Deferred tax assets, net  $5,622   $11,656 

Capital Losses – U.S.

The Company’s tax effected capital losses at March 31, 2025 were $18,563. These capital losses expire between the years 2025 and 2030. During the three months ended March 31, 2025, tax effected capital losses in the amount of $3,460 expired.

Net Operating Losses – Europe

One of the Company’s European subsidiaries generated net operating losses (“NOLs”) outside the U.S. These tax effected NOLs, all of which are carried forward indefinitely, were $998 at March 31, 2025.

 25 
 Table of Contents

Valuation Allowance

The Company’s valuation allowance has been established on its net capital losses (net of unrealized gains), as it is more-likely-than-not that these deferred tax assets will not be realized.

Income Tax Examinations

The Company is subject to U.S. federal income tax as well as income tax of multiple state, local and certain foreign jurisdictions. As of March 31, 2025, with few exceptions, the Company was no longer subject to income tax examinations by any taxing authority for the years before 2020.

Uncertain Tax Positions

There were no unrecognized tax benefits at March 31, 2025 and December 31, 2024.

Undistributed Earnings of Foreign Subsidiaries

ASC 740-30, Income Taxes, provides guidance that U.S. companies do not need to recognize tax effects on foreign earnings that are indefinitely reinvested. The Company repatriates earnings of its foreign subsidiaries and therefore has recognized a deferred tax liability of $109 and $92 at March 31, 2025 and December 31, 2024, respectively.

19. Shares Repurchased

On February 22, 2022, the Company’s Board of Directors approved an increase of $85,709 to the Company’s share repurchase program to $100,000 and extended the term for three years through April 27, 2025. On February 24, 2025, the Company’s Board of Directors approved another increase of $129,158 to the repurchase program, bringing the total authorization to $150,000, and extended the program’s term for another three years through April 27, 2028. Included under the Company’s share repurchase program are purchases to offset future equity grants made under the Company’s equity plans and purchases made in open market or privately negotiated transactions. This authority may be exercised from time to time, subject to regulatory considerations. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions and other corporate liquidity requirements and priorities. The repurchase program may be suspended or terminated at any time without prior notice. Shares repurchased under this program are returned to the status of authorized and unissued on the Company’s books and records.

During the three months ended March 31, 2025 and 2024, the Company repurchased 1,282,498 and 1,096,278 shares of its common stock under this program for an aggregate cost of $12,714 and $7,820, respectively. Shares repurchased under this program were returned to the status of authorized and unissued on the Company’s books and records.

As of March 31, 2025, $149,980 remained under this program for future purchases.

20. Goodwill and Intangible Assets

Goodwill

The table below sets forth goodwill which is tested annually for impairment on November 30th:

  

Total

Balance at January 1, 2025   $86,841 
Changes    
 
Balance at March 31, 2025   $86,841 

Of the total goodwill of $86,841 at March 31, 2025, $85,042 is not deductible for tax purposes as the acquisitions that gave rise to the goodwill were structured as stock acquisitions. The remainder of the goodwill is deductible for U.S. tax purposes.

 26 
 Table of Contents

Intangible Assets

The table below sets forth the Company’s intangible assets which are tested annually for impairment on November 30th:

   Balance at March 31, 2025
Item  Gross Asset  Accumulated
Amortization
  Net Asset
ETFS Acquisition  $601,247   $
   $601,247 
Software development   7,432    (2,645)   4,787 
Balance at March 31, 2025  $608,679   $(2,645)  $606,034 

 

   Balance at December 31, 2024
Item  Gross Asset  Accumulated
Amortization
  Net Asset
ETFS Acquisition  $601,247   $
   $601,247 
Software development   6,855    (2,206)   4,649 
Balance at December 31, 2024  $608,102   $(2,206)  $605,896 

ETFS Acquisition (Indefinite-Lived)

In connection with the ETFS Acquisition, which was completed on April 11, 2018, the Company identified intangible assets valued at $601,247 related to the right to manage AUM through customary advisory agreements. These intangible assets were determined to have indefinite useful lives and are not deductible for tax purposes.

Software Development (Finite-Lived)

Internally-developed software is amortized over a useful life of three years. During the three months ended March 31, 2025 and 2024, the Company recognized amortization expense on internally-developed software of $439 and $327, respectively.

As of March 31, 2025, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows:

Remainder of 2025   $1,602 
2026    1,865 
2027    976 
2028    343 
2029 and thereafter    1 
Total expected amortization expense   $4,787 

The weighted-average remaining useful life of the finite-lived intangible assets is 2.3 years.

21. Segment Information

The Company, through its subsidiaries in the U.S. and Europe, offers a diverse suite of ETPs, models, solutions and products leveraging blockchain technology. The Company conducts business as a single operating segment as an ETP sponsor and asset manager, which is based upon the Company’s current organizational and management structure, as well as information used by the CODM to allocate resources and assess performance and other factors. The accounting policies of the segment are the same as those described in Note 2.

The key measures of segment profit or loss that the CODM uses to allocate resources and assess performance are the Company’s consolidated net income, as reported on the Consolidated Statements of Operations, as well as adjusted operating income and adjusted operating income margin, which are exclusive of items that are non-recurring or not core to the Company’s operating business.

 27 
 Table of Contents

The table below discloses these key measures and is inclusive of a reconciliation of the Company’s operating income and operating income margin as computed under U.S. GAAP to the Company’s Non-GAAP adjusted operating income and adjusted operating income margin utilized by the CODM:

  

Three Months Ended

March 31,

   2025  2024
Net income  $24,629   $22,111 
           
Adjusted Operating Income Margin          
Operating revenues  $108,082   $96,838 
Less: Legal expenses covered by insurance   
    (453)
Operating revenues, as adjusted  $108,082   $96,385 
Operating income  $34,162   $27,950 
Add back: Expenses incurred in response to an activist campaign   
    695 
Adjusted operating income  $34,162   $28,645 
Operating income margin   31.6%   28.9% 
Adjusted operating income margin   31.6%    29.7% 

Expenses incurred in response to an activist campaign for the three months ended March 31, 2024 include $695 of professional fees.

All expense categories on the Consolidated Statements of Operations are significant and there are no other significant segment expenses that would require disclosure. Assets provided to the CODM are consistent with those reported on the Consolidated Balance Sheets with particular emphasis on the Company’s available liquidity, including its cash, cash equivalents and restricted cash, financial instruments owned, accounts receivable and securities held-to-maturity, reduced by current liabilities, seed capital and regulatory capital requirements.

There are no intra-entity sales or transfers and no significant expense categories regularly provided to the CODM beyond those disclosed in the Consolidated Statements of Operations. The CODM manages the business using consolidated expense information, adjusted for items that are non-recurring or not core to the Company’s operating business as disclosed in the table above, as well as regularly provided budgeted or forecasted expense information for the single operating segment.

Information related to the Company’s products and services and geographical distribution of revenues is disclosed in Note 13.

22. Subsequent Events

The Company evaluated subsequent events through the date of issuance of the consolidated financial statements. There were no events requiring disclosure.

 28 
 Table of Contents

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and the related notes and the other financial information included elsewhere in this Report. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below. For a more complete description of the risks noted above and other risks that could cause our actual results to materially differ from our current expectations, please see Item 1A “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. We assume no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

Executive Summary

We are a global financial innovator, offering a diverse suite of ETPs, models, solutions and products leveraging blockchain technology. Our offerings empower investors to shape their financial future and equip financial professionals to grow their businesses. Leveraging the latest financial infrastructure, we create products that emphasize access, transparency and provide an enhanced user experience. Building on our heritage of innovation, we have introduced next-generation digital products and services, including Digital Funds, tokenized assets, and our blockchain-native digital wallet, WisdomTree Prime, which is currently available in 47 U.S. states, covering approximately 85% of the U.S. population. Our institutional platform, WisdomTree Connect, further expands access to our products.

As of March 31, 2025, we managed approximately $115.8 billion in AUM. Our ETPs span a broad range of strategies including equities, fixed income, commodities, leveraged-and-inverse, currency, alternatives and cryptocurrency exposures. We have launched many first-to-market products and pioneered a unique alternative-weighting approach called “Modern Alpha” that combines the outperformance potential of active management with the cost effective benefits of passive management.

Our products are distributed across all major asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers, primarily through our dedicated sales team. We believe technology is transforming how financial advisors conduct business, and through our Advisor and Portfolio Solutions programs we offer technology-enabled and research-driven solutions. These include portfolio construction, asset allocation, practice management services and digital tools to help advisors address technology challenges and scale their businesses.

As pioneers in tokenization and blockchain technology, we view this as the next phase in the evolution in financial services. Through our digital assets strategy, we are committed to “responsible DeFi,” aligning with regulatory standards to foster growth in this rapidly evolving space. We believe that expanding into digital assets and blockchain-enabled finance not only complements our core competencies, but will diversify our revenue streams and further contribute to our growth.

We were incorporated under the laws of the state of Delaware on September 19, 1985 as Financial Data Systems, Inc. and were ultimately renamed WisdomTree, Inc. on November 7, 2022.

 29 
 Table of Contents

Assets Under Management

WisdomTree ETPs

We offer ETPs covering equity, fixed income, commodities and currency, leveraged-and-inverse, alternatives and cryptocurrency. The chart below sets forth the asset mix of our ETPs at March 31, 2024, December 31, 2024 and March 31, 2025:

Market Environment

The first quarter of 2025 was characterized by global volatility. U.S. equities declined amid concerns over tariffs, while European markets outperformed, supported in part by Germany’s announced fiscal stimulus measures. Investor uncertainty surrounding the potential impact of tariffs on global economic growth contributed to increased demand for safe haven assets, including gold, which experienced significant price appreciation during the quarter. In March 2025, the U.S. Federal Reserve revised its 2025 U.S. GDP growth forecast for 2025 downward to 1.7% from 2.1% and increased its inflation outlook to 2.7% from 2.5%. The federal funds target rate remained unchanged during the quarter, within a range of 4.25% to 4.50%.

While the volatility factors above have inevitably impacted our overall AUM, our diverse and balanced AUM mix has provided relative stability, enabling us to mitigate the severity of declines compared to broader market indices. Our strategic emphasis on diversification, including exposure across asset classes, geographic regions and investment strategies, has allowed us to maintain resilience during periods of elevated uncertainty, underscoring the strength and effectiveness of our business model. However, fluctuations in our AUM attributable to market conditions outside of our control have had, and in the future could have, a negative impact on our revenues and operating margins.

During the quarter, the MSCI EAFE Index (local currency), MSCI EMU Index (local currency), MSCI Emerging Markets Index (U.S. dollar) and gold prices increased by 3.0%, 7.7%, 3.0% and 19.3%, respectively, while the S&P 500 and the MSCI Japan Index (local currency) decreased by 4.3% and 4.4%, respectively. The U.S. dollar weakened 2.5%, 1.8% and 0.1% versus the euro, British pound and Japanese yen, respectively, during the quarter.

 30 
 Table of Contents

U.S. Listed ETF Industry Flows

U.S. listed ETF industry net flows were $286.4 billion for the three months ended March 31, 2025. U.S. equity and fixed income gathered the majority of those flows. 

 

Source: Morningstar

 31 
 Table of Contents

European Listed ETP Industry Flows

European listed ETP industry net flows were $65.2 billion for the three months ended March 31, 2025. Equity and fixed income gathered the majority of those flows.

 

Source: Morningstar

 32 
 Table of Contents

Our Operating and Financial Results

We operate as an ETP sponsor and asset manager, providing investment advisory services globally through our subsidiaries in the U.S. and Europe.

U.S. Listed ETFs

The AUM of our U.S. listed exchange traded funds, or U.S. listed ETFs, increased from $79.1 billion at December 31, 2024 to $80.5 billion at March 31, 2025 due to net inflows, partly offset by market depreciation.

European Listed ETPs

The AUM of our European listed (including internationally cross-listed) ETPs, or European listed ETPs, increased from $30.7 billion at December 31, 2024 to $35.1 billion at March 31, 2025 due to market appreciation and net inflows.

 33 
 Table of Contents

Consolidated Operating Results

The following table sets forth our revenues and net income/(loss) for the most recent five quarters.

Revenues – Total revenues increased 11.6% from the three months ended March 31, 2024 to $108.1 million in the comparable period in 2025 due to higher average AUM and higher other revenues attributable to our European listed exchange-traded products.
Expenses – Total operating expenses increased 7.3% from the three months ended March 31, 2024 to $73.9 million in the comparable period in 2025 primarily due to higher stock-based compensation expense and increased headcount, as well as higher third-party distribution fees, fund management and administration expenses, sales and business development expenses and marketing expenses. These increases were partly offset by lower professional fees.
Other Income/(Expenses) – Other income/(expenses) includes interest income and interest expense , impairments and other losses and gains. Further information is provided herein.
Net income – We reported net income of $24.6 million and $22.1 million during the three months ended March 31, 2025 and 2024, respectively.

Guidance Update for the Year Ending December 31, 2025

Compensation to Revenue Ratio

Our compensation to revenue ratio for the year ending December 31, 2025 is currently estimated to range from 28% to 30% (unchanged from our guidance provided last quarter) and takes into consideration planned hires as well as year-end compensation adjustments and the annualization of hires made during 2024. The range also considers variability in incentive compensation with drivers including the magnitude of our flows, revenues and operating income growth, margin expansion and our stock price performance in relation to our peers. A range is provided in consideration of uncertain market conditions.

Discretionary Spending

Discretionary spending includes marketing, sales, professional fees, occupancy and equipment, depreciation and amortization and other expenses. During the three months ended March 31, 2025, our discretionary spending was $16.3 million. We currently estimate our discretionary spending for the year ending December 31, 2025 to range from $68.0 million to $72.0 million (unchanged from our guidance range provided last quarter).

Gross Margin

We define gross margin as total operating revenues less fund management and administration expenses. Gross margin percentage is calculated as gross margin divided by total operating revenues. Our gross margin was 80.8% during the three months ended March 31, 2025. For the year ending December 31, 2025, we currently estimate that our gross margin percentage will be 81.0% to 82.0% (unchanged from our guidance range provided last quarter). We anticipate our gross margin to be at the lower end of this range taking into consideration current AUM and revenue levels. If AUM increases from continued organic growth or favorable market conditions, we would anticipate trending toward the middle to upper end of this range.

 34 
 Table of Contents

Third-Party Distribution Fees

We currently estimate third-party distribution expense to be approximately $11.0 million to $12.0 million for the year ending December 31, 2025 (unchanged from our guidance range provided last quarter), which is dependent upon the AUM growth on our respective platforms.

Interest Expense

We currently estimate our interest expense for the year ending December 31, 2025 to be $22.0 million (unchanged from our guidance range provided last quarter), which is inclusive of approximately $2.0 million of interest cost we are required to impute under U.S. GAAP related to our interest-free financing of the shares of Series C Non-Voting Convertible Preferred Stock (the “Series C Preferred Stock”) we repurchased from Gold Bullion Holdings (Jersey) Limited (“GBH”), a subsidiary of the World Gold Council, in November 2023.

Interest Income

We currently estimate our interest income for the year ending December 31, 2025 to be $8.0 million (previously $7.0 million), based upon the magnitude of our forecasted interest earning assets.

Income Tax Expense

We currently estimate that our consolidated normalized effective tax rate will be approximately 24.0% to 25.0% for the year ending December 31, 2025 (unchanged from the guidance range provided last quarter), taking into consideration the current distribution of profits between the U.S. and Europe.

This estimated rate may change and is dependent upon our actual taxable income earned in relation to our forecasts as well as any other items which may arise that are not currently forecasted. Such items may include, but are not limited to, increases or decreases in valuation allowances and any stock-based compensation windfalls or shortfalls. Additional corporate tax legislation could also impact our normalized effective tax rate.

Weighted Average Diluted Shares

We currently estimate our weighted average diluted shares to be between 147.0 million and 149.0 million during the year ending December 31, 2025. This guidance does not take into consideration any variability in shares associated with our Convertible Notes. While our Convertible Notes require principal to be paid in cash, our diluted shares would need to be increased for any incremental shares associated with an exercise of the conversion option if our stock price exceeds the applicable conversion price of our Convertible Notes of $9.54 per share for the 5.75% Convertible Senior Notes due 2028, $11.04 per share for the 3.25% Convertible Senior Notes due 2026 and $11.82 per share for the 3.25% Convertible Senior Notes due 2029.

Key Operating Statistics

The following table presents key operating statistics that serve as indicators for the performance of our business:

   Three Months Ended
  

Mar. 31,

2025

 

Dec. 31,

2024

 

Mar. 31,

2024

GLOBAL PRODUCTS ($ in millions)         
          
Beginning of period assets  $109,779   $112,577   $100,124 
Add: Digital Assets—Jan. 1, 2025   32         
Inflows/(outflows)   3,048    (281)   1,988 
Market appreciation/(depreciation)   2,928    (2,517)   5,118 
End of period assets  $115,787   $109,779   $107,230 
Average assets during the period  $114,622   $112,349   $102,461 
Average advisory fee during the period   0.35%   0.36%   0.36%
Revenue days   90    92    91 
Number of products—end of the period   375(1)   353    338 
 35 
 Table of Contents
   Three Months Ended
  

Mar. 31,

2025

 

Dec. 31,

2024

 

Mar. 31,

2024

U.S. LISTED ETFs ($ in millions)         
          
Beginning of period assets  $79,095   $81,267   $72,486 
Inflows/(outflows)   1,843    (40)   1,983 
Market (depreciation)/appreciation   (407)   (2,132)   3,618 
End of period assets  $80,531   $79,095   $78,087 
Average assets during the period  $81,127   $80,661   $74,831 
Number of ETFs—end of the period   95    78    77 
                
EUROPEAN LISTED ETPs ($ in millions)               
                
Beginning of period assets  $30,684   $31,310   $27,638 
Inflows/(outflows)   1,104    (241)   5 
Market appreciation/(depreciation)   3,336    (385)   1,500 
End of period assets  $35,124   $30,684   $29,143 
Average assets during the period  $33,415   $31,688   $27,630 
Number of ETPs—end of the period   280    275    261 
                
DIGITAL ASSETS ($ in millions)               
                
Beginning of period assets  $   $   $ 
Add: Digital Assets—Jan. 1, 2025   32         
Inflows   101         
Market depreciation   (1)        
End of period assets  $132   $   $ 
Average assets during the period  $80   $   $ 
Number of products—end of the period   17(1)        
                
PRODUCT CATEGORIES ($ in millions)               
                
U.S. Equity               
Beginning of period assets  $35,414   $34,643   $29,156 
Add: Digital Assets—Jan. 1, 2025   9         
Inflows   963    1,099    536 
Market (depreciation)/appreciation   (758)   (328)   1,978 
End of period assets  $35,628   $35,414   $31,670 
Average assets during the period  $36,281   $35,714   $30,154 
                
Commodity & Currency               
Beginning of period assets  $21,906   $23,034   $21,336 
Add: Digital Assets—Jan. 1, 2025   1         
Outflows   (159)   (440)   (460)
Market appreciation/(depreciation)   3,739    (688)   1,068 
End of period assets  $25,487   $21,906   $21,944 
Average assets during the period  $23,993   $22,989   $20,837 
                
Fixed Income               
Beginning of period assets  $20,043   $20,767   $21,197 
Add: Digital Assets—Jan. 1, 2025   21         
Inflows/(outflows)   2,088    (387)   (14)
Market appreciation/(depreciation)   78    (337)   35 
End of period assets  $22,230   $20,043   $21,218 
Average assets during the period  $21,464   $20,398   $21,082 
 36 
 Table of Contents
   Three Months Ended
  

Mar. 31,

2025

 

Dec. 31,

2024

 

Mar. 31,

2024

International Developed Market Equity               
Beginning of period assets  $17,602   $18,075   $15,103 
Inflows   474    63    1,597 
Market appreciation/(depreciation)   102    (536)   1,403 
End of period assets  $18,178   $17,602   $18,103 
Average assets during the period  $18,275   $17,716   $16,691 
                
Emerging Market Equity               
Beginning of period assets  $10,468   $12,452   $10,726 
(Outflows)/inflows   (445)   (908)   217 
Market (depreciation)/appreciation   (38)   (1,076)   246 
End of period assets  $9,985   $10,468   $11,189 
Average assets during the period  $10,072   $11,407   $10,900 
                
Leveraged & Inverse               
Beginning of period assets  $1,924   $2,082   $1,815 
Inflows/(outflows)   116    (69)   (50)
Market appreciation/(depreciation)   93    (89)   63 
End of period assets  $2,133   $1,924   $1,828 
Average assets during the period  $2,083   $2,032   $1,792 
                
Cryptocurrency               
Beginning of period assets  $1,912   $1,054   $414 
Add: Digital Assets—Jan. 1, 2025   1         
(Outflows)/inflows   (89)   315    158 
Market (depreciation)/appreciation   (271)   543    302 
End of period assets  $1,553   $1,912   $874 
Average assets during the period  $1,900   $1,599   $614 
                
Alternatives               
Beginning of period assets  $510   $470   $377 
Inflows   100    46    4 
Market (depreciation)/appreciation   (17)   (6)   23 
End of period assets  $593   $510   $404 
Average assets during the period  $554   $494   $391 
                
Headcount   315    313    300 

_____________________________

(1)Includes 17 digital assets products, which were launched prior to January 1, 2025.

Note: Previously issued statistics may be restated due to fund closures and trade adjustments.

Source: WisdomTree

 37 
 Table of Contents

Three Months Ended March 31, 2025 Compared to Three Months Ended March 31, 2024

Selected Operating and Financial Information

   Three Months Ended
March 31,
     Percent
   2025  2024  Change  Change
AUM (in millions)                    
Average AUM  $114,622   $102,461   $12,161    11.9% 
Operating Revenues (in thousands)                    
Advisory fees  $99,549   $92,501   $7,048    7.6% 
Other revenues   8,533    4,337    4,196    96.7% 
Total operating revenues  $108,082   $96,838   $11,244    11.6% 

Operating Revenues

Advisory fees

Advisory fee revenues increased 7.6% from $92.5 million during the three months ended March 31, 2024 to $99.5 million in the comparable period in 2025 due to higher average AUM. Our average advisory fee was 0.35% during the three months ended March 31, 2025 and 0.36% during the three months ended March 31, 2024.

Other revenues

Other revenues increased 96.7% from $4.3 million during the three months ended March 31, 2024 to $8.5 million in the comparable period in 2025 due to higher other revenues attributable to our European listed ETPs.

Operating Expenses

   Three Months Ended
March 31,
     Percent
(in thousands)  2025  2024  Change  Change
Compensation and benefits  $33,788   $31,054   $2,734    8.8% 
Fund management and administration   20,714    19,962    752    3.8% 
Marketing and advertising   4,813    4,408    405    9.2% 
Sales and business development   4,137    3,611    526    14.6% 
Professional fees   2,782    3,630    (848)   (23.4%)
Occupancy, communications and equipment   1,482    1,210    272    22.5% 
Depreciation and amortization   540    383    157    41.0% 
Third-party distribution fees   3,112    2,307    805    34.9% 
Other   2,552    2,323    229    9.9% 
Total operating expenses  $73,920   $68,888   $5,032    7.3% 
    

Three Months Ended
March 31,

           
As a Percent of Revenues:   2025    2024           
Compensation and benefits   31.1%   32.1%           
Fund management and administration   19.2%    20.6%           
Marketing and advertising   4.5%    4.6%           
Sales and business development   3.8%    3.7%           
Professional fees   2.6%    3.7%           
Occupancy, communications and equipment   1.4%    1.2%           
Depreciation and amortization   0.5%    0.4%           
Third-party distribution fees   2.9%    2.4%           
Other   2.4%    2.4%           
Total operating expenses   68.4%    71.1%           

Compensation and benefits

Compensation and benefits expense increased 8.8% from $31.1 million during the three months ended March 31, 2024 to $33.8 million in the comparable period in 2025 due to higher stock-based compensation expense and increased headcount. Headcount was 300 and 315 at March 31, 2024 and 2025, respectively.

 38 
 Table of Contents

Fund management and administration

Fund management and administration expense increased 3.8% from $20.0 million during the three months ended March 31, 2024 to $20.7 million in the comparable period in 2025 primarily due to higher average AUM. We had 78 U.S. listed ETFs and 275 European listed ETPs at March 31, 2024 compared to 78 U.S. listed ETFs, 280 European listed ETPs and 17 digital assets products at March 31, 2025.

Marketing and advertising

Marketing and advertising expense increased 9.2% from $4.4 million during the three months ended March 31, 2024 to $4.8 million in the comparable period in 2025 primarily due to higher spend related to our U.S. listed ETFs.

Sales and business development

Sales and business development expense increased 14.6% from $3.6 million during the three months ended March 31, 2024 to $4.1 million in the comparable period in 2025 primarily due to increases in travel and events spending, as well as higher spending on sales tools and data.

Professional fees

Professional fees expense decreased 23.4% from $3.6 million during the three months ended March 31, 2024 to $2.8 million in the comparable period in 2025 as the prior period included activist campaign expenses and expenses incurred in connection with a settlement with the U.S. Securities and Exchange Commission regarding certain statements about the ESG screening process for three ETFs advised by WisdomTree Asset Management, Inc. (the “SEC ESG Settlement”).

Occupancy, communications and equipment

Occupancy, communications and equipment expense increased 22.5% from $1.2 million during the three months ended March 31, 2024 to $1.5 million in the comparable period in 2025 primarily due to higher internet and communications expenses.

Depreciation and amortization

Depreciation and amortization expense increased 41.0% from $0.4 million during the three months ended March 31, 2024 to $0.5 million in the comparable period in 2025 primarily due to higher amortization of capitalized software.

Third-party distribution fees

Third-party distribution fees expense increased 34.9% from $2.3 million during the three months ended March 31, 2024 to $3.1 million in the comparable period in 2025 due to growth in AUM across our various platforms.

Other

Other expenses were essentially unchanged from the three months ended March 31, 2024.

Other Income/(Expenses)

   Three Months Ended
March 31,
    Percent
(in thousands)  2025  2024  Change  Change
Interest expense  $(5,441)  $(4,128)  $(1,313)   31.8%
Interest income   1,897    1,398    499    35.7% 
Other losses and gains, net   (250)   2,592    (2,842)   n/a 
Total other expenses, net  $(3,794)  $(138)  $(3,656)   2,649.3% 
    

Three Months Ended
March 31,

           
As a Percent of Revenues:   2025    2024           
Interest expense   (5.1%)   (4.2%)          
Interest income   1.8%   1.4%           
Other losses and gains, net   (0.2%)   2.7%           
Total other expenses, net   (3.5%)   (0.1%)          

Interest expense

Interest expense increased 31.8% from $4.1 million during the three months ended March 31, 2024 to $5.4 million in the comparable period in 2025 due to a higher level of debt outstanding, partly offset by a lower average interest rate. Our effective interest rate during the three months ended March 31, 2024 and 2025 was 5.0% and 3.9%, respectively.

 39 
 Table of Contents

Interest income

Interest income increased 35.7% from $1.4 million during the three months ended March 31, 2024 to $1.9 million in the comparable period in 2025 due to a higher level of interest earning assets.

Other losses and gains, net

Other losses and gains, net were $2.6 million and ($0.3) million during the three months ended March 31, 2024 and 2025, respectively. The three months ended March 31, 2025 includes net losses of $0.4 million on our financial instruments and net gains of $0.3 million on our investments. Gains and losses also generally arise from the sale of gold earned from management fees paid by our physically-backed gold ETPs, foreign exchange fluctuations and other miscellaneous items.

Income Taxes

Our effective income tax rate during the three months ended March 31, 2025 was 18.9%, resulting in income tax expense of $5.7 million. The effective tax rate differs from the federal statutory rate of 21.0% primarily due to tax windfalls associated with the vesting of stock-based compensation awards and a lower tax rate on foreign earnings. These items were partly offset by state and local income taxes and non-deductible executive compensation.

Our effective income tax rate during the three months ended March 31, 2024 was 20.5%, resulting in income tax expense of $5.7 million. The effective tax rate differs from the federal statutory rate of 21% primarily due to the decrease in the deferred tax asset valuation allowance on losses recognized on our financial instruments owned, tax windfalls associated with the vesting of stock-based compensation awards and a lower tax rate on foreign earnings. These items were partly offset by state and local income taxes.

Non-GAAP Financial Measurements

In an effort to provide additional information regarding our results as determined by GAAP, we also disclose certain non-GAAP information which we believe provides useful and meaningful information. Our management reviews these non-GAAP financial measurements when evaluating our financial performance and results of operations; therefore, we believe it is useful to provide information with respect to these non-GAAP measurements so as to share this perspective of management. Non-GAAP measurements do not have any standardized meaning, do not replace nor are they superior to GAAP financial measurements and are unlikely to be comparable to similar measures presented by other companies. These non-GAAP financial measurements should be considered in the context with our GAAP results. The non-GAAP financial measurements contained in this Report include:

Adjusted Net Income and Diluted Earnings per Share

We disclose adjusted net income and diluted earnings per share as non-GAAP financial measurements in order to report our results exclusive of items that are non-recurring or not core to our operating business. We believe presenting these non-GAAP financial measurements provides investors with a consistent way to analyze our performance. These non-GAAP financial measurements exclude the following:

Legal and other related expenses covered by insurance: During the year ended December 31, 2024, we incurred $4.3 million of legal and other related expenses in connection with the SEC ESG Settlement. These expenses were covered by insurance and reimbursed on April 7, 2025. GAAP requires that such covered expenses be reported gross in the income statement such that revenues are recorded to offset expenses incurred. We offset the revenues and related expenses when calculating our non-GAAP financial measurements as the gross presentation serves to overstate our revenues and expenses recognized in the ordinary course of business.
Gains or losses on financial instruments owned: We account for our financial instruments owned as trading securities, which requires these instruments to be measured at fair value with gains and losses reported in net income. We exclude these items when calculating our non-GAAP financial measurements as the gains and losses introduce volatility in earnings and are not core to our operating business.
Tax windfalls and shortfalls upon vesting of stock-based compensation awards: GAAP requires the recognition of tax windfalls and shortfalls within income tax expense. These items arise upon the vesting of stock-based compensation awards and the magnitude is directly correlated to the number of awards vesting/exercised, as well as the difference between the price of our stock on the date the award was granted and the date the award vested or was exercised. We exclude these items when calculating our non-GAAP financial measurements as they introduce volatility in earnings and are not core to our operating business.
Imputed interest on our payable to GBH: During the fourth quarter of 2023, we repurchased our Series C Preferred Stock, which was convertible into approximately 13.1 million shares of our common stock, from GBH for aggregate cash consideration of approximately $84.4 million. Under the terms of the transaction, we paid GBH $40.0 million on the closing date, with the remainder of the purchase price payable in equal annual installments on the first, second and third anniversaries of the closing date, with no requirement to pay interest. Under U.S. GAAP, the obligation is recorded at its present value utilizing a market rate of interest on the closing date of 7.0% and the corresponding discount is amortized as interest expense pursuant to the effective interest method of accounting over the life of the obligation. We exclude this item when calculating our non-GAAP financial measurements as recognition of interest expense is non-cash and contrary to the stated terms of our obligation.

 40 
 Table of Contents
Other items: Gains and losses recognized on our investments, changes in deferred tax asset valuation allowance and expenses incurred in response to an activist campaign are excluded when calculating our non-GAAP financial measurements.

   Three Months Ended

 

Adjusted Net Income and Diluted Earnings per Share:

 

Mar. 31,

2025

 

Mar. 31,

2024

Net income, as reported  $24,629   $22,111 
Deduct: Tax windfalls upon vesting of stock-based compensation awards   (2,083)   (699)
Add back: Imputed interest on payable to GBH, net of income taxes   344    504 
Add back/(deduct): Losses/(gains) on financial instruments owned, net of income taxes   333    (1,562)
Deduct: Gains recognized on investments, net of income taxes   (239)   (93)
Add back/(deduct): Increase/(decrease) in deferred tax asset valuation allowance on financial instruments owned and investments   30    (531)
Add back: Expenses incurred in response to an activist campaign, net of income taxes       526 
Adjusted net income  $23,014   $20,256 
Deduct: Income distributed to participating securities       (462)
Deduct: Undistributed income allocable to participating securities   (22)   (1,446)
Adjusted net income available to common stockholders  $22,992   $18,348 
Weighted average diluted shares, excluding participating securities (in thousands) (See Note 17 to our Consolidated Financial Statements)   146,379    149,989 
Adjusted earnings per share – diluted  $0.16   $0.12 

Liquidity and Capital Resources

The following table summarizes key data regarding our liquidity, capital resources and use of capital to fund our operations:

  

March 31,

2025

 

December 31,

2024

Balance Sheet Data (in thousands):      
Cash, cash equivalents and restricted cash  $170,373   $181,191 
Financial instruments owned, at fair value   85,294    85,439 
Accounts receivable   46,125    44,866 
Total: Liquid assets   301,792    311,496 
Less: Total current liabilities   (81,864)   (109,197)
Less: Other assetsseed capital (WisdomTree Digital Funds)   (20,848)   (20,866)
Less: Regulatory capital requirements   (35,580)   (39,423)
Total: Available liquidity  $163,500   $142,216 
    
   Three Months Ended March 31,
  

2025

 

2024

Cash Flow Data (in thousands):      
Operating cash flows  $6,370   $(1,038)
Investing cash flows   (214)   2,028 
Financing cash flows   (19,208)   (12,817)
Foreign exchange rate effect   2,234    (552)
Decrease in cash, cash equivalents and restricted cash  $(10,818)  $(12,379)

Liquidity

We consider our available liquidity to be our liquid assets, less our current liabilities, seed capital in WisdomTree Digital Funds and regulatory capital requirements of certain of our subsidiaries. Liquid assets consist of cash, cash equivalents and restricted cash, financial instruments owned, at fair value, accounts receivable and securities held-to-maturity. Our financial instruments owned, at fair value are highly liquid investments. Accounts receivable are current assets and primarily represent receivables from advisory fees we earn from our ETPs. Our current liabilities consist primarily of payments owed to vendors and third parties in the normal course of business and accrued incentive compensation for employees.

 41 
 Table of Contents

Cash, cash equivalents and restricted cash decreased by $10.8 million during the three months ended March 31, 2025 due to $12.7 million used to repurchase our common stock, $4.6 million used to pay dividends, $1.9 million of excise tax paid on common stock repurchased and $0.6 million used to pay for software development. These decreases were partly offset by $6.4 million provided from operating activities, $0.4 million of proceeds from the sale of financial instruments owned, at fair value and $2.2 million from other activities.

Cash, cash equivalents and restricted cash decreased by $12.4 million during the three months ended March 31, 2024 due to $7.8 million used to repurchase our common stock, $5.0 million used to pay dividends, $2.5 million used to purchase financial instruments owned, at fair value, $1.0 million used in operating activities, $0.6 million used to pay for software development and $0.7 million used for other activities. These decreases were partly offset by $5.2 million of proceeds from the sale of financial instruments owned, at fair value.

Convertible Notes

We have the following convertible notes outstanding as of March 31, 2025:

$150.0 million in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the “2026 Notes”);
$25.8 million in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the “2028 Notes”); and
$345.0 million in aggregate principal amount of 3.25% Convertible Senior Notes due 2029 (the “2029 Notes”).

Each class of notes were issued pursuant to indentures dated as of the issuance dates between us and U.S. Bank Trust Company, National Association, as trustee (either initially or as successor to U.S. Bank National Association, the “Trustee”), in private offerings to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

As of March 31, 2025, we had an aggregate principal amount of $520.8 million outstanding of the 2026 Notes, the 2028 Notes and the 2029 Notes (collectively, the “Convertible Notes”).

Key terms of the Convertible Notes are as follows:

   2026 Notes  2028 Notes  2029 Notes
Principal outstanding  $150.0   $25.8   $345.0 
Issuance date  June 14, 2021   February 14, 2023   August 13, 2024 
Maturity date (unless earlier converted, repurchased or redeemed)  June 15, 2026   August 15, 2028   August 15, 2029 
Interest rate  3.25%  5.75%  3.25%
Initial conversion price  $11.04   $9.54   $11.82 
Initial conversion rate  90.5797   104.8658   84.5934 
Redemption price  $14.35   $12.40   $15.37 
Interest rate: Payable semiannually in arrears on February 15 and August 15 of each year for the 2029 Notes and the 2028 Notes and on June 15 and December 15 of each year for the 2026 Notes.
Conversion price: Convertible at an initial conversion rate into shares of our common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.
Conversion: Holders may convert at their option at any time prior to the close of business on the business day immediately preceding May 15, 2029 and May 15, 2028 for the 2029 Notes and the 2028 Notes, respectively, and March 15, 2026 for the 2026 Notes, only under the following circumstances: (i) if the last reported sale price of our common stock for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sales price of our common stock and the conversion rate on each such trading day; (iii) upon a notice of redemption delivered by us in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv) upon the occurrence of specified corporate events. On or after May 15, 2029 and May 15, 2028 in respect of the 2029 Notes and the 2028 Notes, respectively, and March 15, 2026 in respect of the 2026 Notes, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.
Cash settlement of principal amount: Upon conversion, we will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At our election, we will also settle the conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of our common stock or a combination of cash and shares of common stock.

 42 
 Table of Contents

Redemption price: We may redeem for cash all or any portion of the Convertible Notes, at our option, on or after August 20, 2026 and August 20, 2025 in respect of the 2029 Notes and the 2028 Notes, respectively, and June 20, 2023 in respect of the 2026 Notes and on or prior to the 55th scheduled trading day immediately preceding the maturity date, if the last reported sale price of our common stock has been at least 130% of the conversion price for the respective Convertible Notes then in effect for at least 20 trading days, including the trading day immediately preceding the date on which we provide notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.
Limited investor put rights: Holders of the Convertible Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.
Conversion rate increase in certain customary circumstances: In certain circumstances, conversions in connection with a “make-whole fundamental change” (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 103.6269 shares, 167.7853 shares and 144.9275 shares of our common stock per $1,000 principal amount of the 2029 Notes, the 2028 Notes and the 2026 Notes, respectively (the equivalent of 61,826,817 shares of our common stock based on the aggregate principal amount of Convertible Notes outstanding), subject to adjustment.
Seniority and Security: The Convertible Notes rank equal in right of payment and are our senior unsecured obligations.

The indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the respective holders of not less than 25% in aggregate principal amount of the respective series of Convertible Notes outstanding may declare the entire principal amount of all such respective Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.

Capital Resources

Our principal source of financing is our operating cash flow. We believe that current cash flows generated by our operating activities and existing cash balances should be sufficient for us to fund our operations for the foreseeable future.

Our ability to satisfy our contractual obligations as they arise are discussed in the section titled “Contractual Obligations” below.

Use of Capital

Our business does not require us to maintain a significant cash position. However, certain of our subsidiaries are required to maintain a minimum level of regulatory capital, which at March 31, 2025 was approximately $35.6 million in the aggregate. Notwithstanding these regulatory capital requirements, we expect that our main uses of cash will be to fund the ongoing operations of our business. We also maintain a capital return program which includes a $0.03 per share quarterly cash dividend and authority to purchase our common stock through April 27, 2028, including purchases to offset future equity grants made under our equity plans and purchases made in open market or privately negotiated transactions.

During the three months ended March 31, 2025, we repurchased 1,282,498 shares of our common stock under the repurchase program for an aggregate cost of $12.7 million. Currently, approximately $150.0 million remains under this program for future purchases.

Contractual Obligations

Convertible Notes

We currently have $520.8 million in aggregate principal amount of Convertible Notes outstanding, of which $150.0 million, $25.8 million and $345.0 million are scheduled to mature on June 15, 2026, August 15, 2028 and August 15, 2029, in respect of the 2026 Notes, the 2028 Notes and the 2029 Notes, respectively, unless earlier converted, repurchased or redeemed. Conditional conversions or a requirement to repurchase the Convertible Notes upon the occurrence of a fundamental change may accelerate payment.

The Convertible Notes require cash settlement of up to the principal amount, while settlement of the conversion obligation in excess of the aggregate principal amount may be satisfied in either cash, shares of our common stock or a combination of cash and shares of our common stock. We may settle and/or refinance these obligations when due

See the section titled “Convertible Notes” above for additional information.

 43 
 Table of Contents

Payable to GBH

On November 20, 2023, we repurchased our Series C Preferred Stock from GBH for aggregate cash consideration of approximately $84.4 million. Under the terms of the transaction, we have paid GBH $54.8 million to date, with the remainder of the purchase price payable in equal, interest-free installments on the second and third anniversaries of the closing date. The implied price per share was $6.02 when considering the interest-free financing element of the transaction.

Operating Leases

Total future minimum lease payments with respect to our operating lease liabilities were $0.6 million at March 31, 2025. Cash flows generated by our operating activities and existing cash balances should be sufficient to satisfy the future minimum lease payments. See Note 10 to our Consolidated Financial Statements for additional information.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet financing or other arrangements and have neither created nor are party to any special-purpose or off-balance sheet entities for the purpose of raising capital, incurring debt or operating our business.

Critical Accounting Policies and Estimates

Goodwill and Intangible Assets

Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. We test goodwill for impairment at least annually and at the time of a triggering event requiring re-evaluation, if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.

Goodwill is allocated to our U.S. and European components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.

Goodwill is assessed for impairment annually on November 30th. When performing our goodwill impairment test, we consider a qualitative assessment, when appropriate, and the market approach and its market capitalization when determining the fair value of the reporting unit. The results of our most recent analysis indicated no impairment based upon a quantitative assessment.

Indefinite-lived intangible assets are tested for impairment at least annually and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are impaired if their estimated fair value is less than their carrying value. We may rely on a qualitative assessment when performing our intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for our intangible assets is November 30th. The results of our most recent analysis identified no indicators of impairment to be recognized based upon a quantitative assessment (discounted cash flow analysis) which relied upon significant unobservable inputs including projected revenue growth rates of 3.0% and a weighted average cost of capital of 10.5%.

Investments

We account for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed within Accounting Standards Codification Topic 321, Investments – Equity Securities, to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment. See Note 6 to our Consolidated Financial Statements for information.

Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).

Revenue Recognition

We earn a significant portion of our revenues in the form of advisory fees from our ETPs and recognize this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs’ average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which we have a right to invoice.

 44 
 Table of Contents

Other revenues are earned from swap providers associated with certain of our European listed ETPs, the nature of which are based on a percentage of the ETPs’ average daily net assets. We also earn transaction-based income on flows associated with certain European listed ETPs. There is no significant judgment in calculating amounts due, which are invoiced monthly or quarterly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which we have a right to invoice.

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The following information, together with information included in other parts of this Management’s Discussion and Analysis of Financial Condition and Results of Operations, describes key aspects of our market risk.

Market Risk

Market risk to us generally represents the risk of changes in the value of our ETPs and Digital Funds that results from fluctuations in securities or commodity prices, foreign currency exchange rates against the U.S. dollar, and interest rates. Nearly all our revenues are derived from advisory agreements for the WisdomTree ETPs. Under these agreements, the advisory fee we receive is based on the average market value of the assets in the WisdomTree ETP portfolios we manage.

Fluctuations in the value of the ETPs are common and are generated by numerous factors such as market volatility, the global economy, inflation, changes in investor strategies and sentiment, availability of alternative investment vehicles, domestic and foreign government regulations, emerging markets developments and others. Accordingly, changes in any one or a combination of these factors may reduce the value of investment securities and, in turn, the underlying AUM on which our revenues are earned. These declines may cause investors to withdraw funds from our ETPs in favor of investments that they perceive as offering greater opportunity or lower risk, thereby compounding the impact on our revenues. We believe challenging and volatile market conditions will continue to be present in the foreseeable future.

Interest Rate Risk

We invest our corporate cash in short-term interest earning assets, primarily in federal agency debt instruments, WisdomTree fixed income ETFs, U.S. treasuries, corporate bonds, money market instruments at a commercial bank and other securities which totaled $134.0 million and $110.0 million as of December 31, 2024 and March 31, 2025, respectively. During the three months ended March 31, 2025, we recognized losses on these financial instruments of $0.4 million and any gains/losses recognized in the future may be material to our operating results. We do not anticipate that changes in interest rates will have a material impact on our financial condition or cash flows.

In addition, our Convertible Notes bear interest at fixed rates of 3.25% for the 2026 Notes and the 2029 Notes and 5.75% for the 2028 Notes, respectively. Therefore, we have no direct financial statement risk associated with changes in interest rates. However, the fair value of the Convertible Notes changes primarily when the market price of our common stock fluctuates or interest rates change.

Exchange Rate Risk

We are subject to currency translation exposure on the results of our non-U.S. operations, primarily in the U.K. and Europe. Foreign currency translation risk is the risk that exchange rate gains or losses arise from translating foreign entities’ statements of earnings and balance sheets from functional currency to our reporting currency (the U.S. dollar) for consolidation purposes. The advisory fees earned on our European listed ETPs are predominantly in U.S. dollars (and also paid in gold, other precious metals and cryptocurrency, as described below); however, expenses for corporate overhead are generally incurred in British pounds. Currently, we do not enter into derivative financial instruments aimed at offsetting certain exposures in the statement of operations or the balance sheet but may seek to do so in the future.

Exchange rate risk associated with the euro is not considered to be significant.

Commodity and Cryptocurrency Price Risk

Fluctuations in the prices of commodities and cryptocurrencies that are linked to certain of our ETPs could have a material adverse effect on our AUM and revenues. In addition, a portion of the advisory fee revenues we receive on our ETPs backed by gold, other precious metals and cryptocurrencies are paid in the underlying metal or cryptocurrency. While we readily sell the gold, precious metals and cryptocurrencies that we earn under these advisory contracts, we still may maintain a position. We currently do not enter into arrangements to hedge against fluctuations in the price of these commodities and cryptocurrencies and any hedging we may undertake in the future may not be cost-effective or sufficient to hedge against this exposure.

 45 
 Table of Contents
ITEM 4.CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of March 31, 2025, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) promulgated under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2025, our disclosure controls and procedures were effective at a reasonable assurance level in ensuring that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules, regulations and forms of the SEC, including ensuring that such material information is accumulated by and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

During the quarter ended March 31, 2025, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II: OTHER INFORMATION

ITEM 1.LEGAL PROCEEDINGS

We may be subject to reviews, inspections and investigations by federal regulators including, but not limited to, the SEC, Commodity Futures Trading Commission (CFTC), National Futures Association (NFA), Financial Industry Regulatory Authority (FINRA), state and foreign regulators, as well as legal proceedings arising in the ordinary course of business. See Note 11 to our Consolidated Financial Statements for additional information regarding actual and potential claims brought by investors in our WisdomTree WTI Crude Oil 3x Daily Leveraged ETP totaling approximately €26.2 million ($28.4 million), including €15.2 million ($16.5 million) of claims resolved in our favor, which have been appealed.

ITEM 1A.RISK FACTORS

You should carefully consider the information set forth in Part 1, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Recent Sales of Unregistered Securities

None.

Use of Proceeds

Not applicable.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

The following table provides information with respect to purchases made by or on behalf of the Company or any “affiliated purchaser” of shares of our common stock.

   Total Number
of Shares
Purchased
  Average Price
Paid Per Share
  Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
  Approximate
Dollar Value of
Shares that
May Yet Be Purchased
Under the Plans or
Programs
Period              (in thousands) 
January 1, 2025 to January 31, 2025   1,280,001   $9.92    1,280,001      
February 1, 2025 to February 28, 2025      $          
March 1, 2025 to March 31, 2025   2,497   $8.50    2,177      
Total   1,282,498   $9.91    1,282,498   $149,980 

On February 24, 2025, our Board of Directors approved an increase of $129.2 million to our share repurchase program, bringing the total authorization to $150.0 million, and extended the program’s term for three years through April 27, 2028. During the three months ended March 31, 2025, we repurchased 1,282,498 shares of our common stock under this program for an aggregate cost of approximately $12.7 million. As of March 31, 2025, $150.0 million remained under this program for future repurchases.

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

None.

 46 
 Table of Contents
ITEM 4.MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.OTHER INFORMATION

10b5-1 Trading Arrangements

On February 25, 2025, R. Jarrett Lilien, our President and Chief Operating Officer, entered into a stock trading plan designed to comply with Rule 10b5-1 under the Exchange Act. Under the terms of the plan, Mr. Lilien will sell up to an aggregate of 75,000 shares of our common stock, subject to certain price limitations set forth in the plan. The plan will terminate on December 15, 2025. The plan was adopted during an open trading window, and no sales will commence under the plan until completion of the required cooling off period.

During the three months ended March 31, 2025, none of our other directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adoptedterminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).

 47 
 Table of Contents
ITEM 6.EXHIBITS

EXHIBIT INDEX

Exhibit
Number
 
  Description
3.1   Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
3.2   Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Name Change) (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on November 7, 2022)
3.3   Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Declassification of Board of Directors) (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on July 20, 2022)
3.4   Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Increase in Authorized Shares) (incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on July 20, 2022)
3.5   Certificate of Designations of Series B Junior Participating Cumulative Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Registration Statement on Form 8-A filed with the SEC on March 20, 2023)
3.6   Certificate of Elimination of Series B Junior Participating Cumulative Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on March 18, 2025)
3.7   Fifth Amended and Restated Bylaws (incorporated by reference to Exhibit 3.7 of the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on August 2, 2024)
4.1   Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
4.2   Amended and Restated Stockholders Agreement among the Registrant and certain investors dated December 21, 2006 (incorporated by reference to Exhibit 4.2 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
4.3   Securities Purchase Agreement among the Registrant and certain investors dated December 21, 2006 (incorporated by reference to Exhibit 4.3 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
4.4   Securities Purchase Agreement among the Registrant and certain investors dated October 15, 2009 (incorporated by reference to Exhibit 4.4 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
4.5   Third Amended and Restated Registration Rights Agreement dated October 15, 2009 (incorporated by reference to Exhibit 4.5 of the Registrant’s Registration Statement on Form 10, filed with the SEC on March 31, 2011)
4.6   Indenture, dated as of June 14, 2021, by and between the Registrant and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on June 14, 2021)
4.7   Form of Global Note, representing the Registrant’s 3.25% Convertible Senior Notes due 2026 (incorporated by reference to Exhibit 4.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on June 14, 2021)
4.8   Indenture, dated as of February 14, 2023, by and between the Registrant and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K, filed with the SEC on February 14, 2023)
4.9   Form of Global Note, representing the Registrant’s 5.75% Convertible Senior Notes due 2028 (incorporated by reference to Exhibit 4.2 of the Registrant’s Current Report on Form 8-K, filed with the SEC on February 14, 2023)
4.10   Indenture, dated as of August 13, 2024, by and between the Registrant and U.S. Bank Trust Company, National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on August 13, 2024)
4.11   Form of Global Note, representing the Registrant’s 3.25% Convertible Senior Notes due 2029 (incorporated by reference to Exhibit 4.2 of the Registrant’s Current Report on Form 8-K filed with the SEC on August 13, 2024)
31.1(1)   Rule 13a-14(a) / 15d-14(a) Certification
31.2(1)   Rule 13a-14(a) / 15d-14(a) Certification
32.1(2)  

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 48 
 Table of Contents

Exhibit
Number
 
  Description
101(1)   Financial Statements from the Quarterly Report on Form 10-Q of the Company for the three months ended March 31, 2025, formatted in XBRL: (i) Consolidated Balance Sheets at March 31, 2025 (Unaudited) and December 31, 2024; (ii) Consolidated Statements of Operations and Comprehensive Income for the three months ended March 31, 2025 and March 31, 2024 (Unaudited); (iii) Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2025 and March 31, 2024 (Unaudited); (iv) Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and March 31, 2024 (Unaudited); and (v) Notes to Consolidated Financial Statements, as blocks of text and in detail.
101.SCH(1)   Inline XBRL Taxonomy Extension Schema Document
101.CAL(1)   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF(1)   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB(1)   Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE(1)   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104(1)   Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*)

__________________________________________________________

(1)Filed herewith.
(2)Furnished herewith.

 49 
 Table of Contents

SIGNATURE

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 9th day of May 2025.

 

  WISDOMTREE, INC.
   
     
  By:  

/s/ Jonathan Steinberg

    Jonathan Steinberg
   

Chief Executive Officer

(Principal Executive Officer)

   
  WISDOMTREE, INC.
   
     
  By:

/s/ Bryan Edmiston

    Bryan Edmiston
   

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

50

 

  

337625 0000880631 false Q1 --12-31 0000880631 2025-01-01 2025-03-31 0000880631 2025-05-06 0000880631 2025-03-31 0000880631 2024-12-31 0000880631 wt:WisdomTreeGovernmentMoneyMarketDigitalFundMember 2025-03-31 0000880631 wt:WisdomTreeGovernmentMoneyMarketDigitalFundMember 2024-12-31 0000880631 wt:WisdomTreeProductsMember 2025-03-31 0000880631 wt:WisdomTreeProductsMember 2024-12-31 0000880631 us-gaap:RelatedPartyMember 2025-03-31 0000880631 us-gaap:RelatedPartyMember 2024-12-31 0000880631 us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember 2025-01-01 2025-03-31 0000880631 us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember 2024-01-01 2024-03-31 0000880631 wt:OtherServicesIncomeMember 2025-01-01 2025-03-31 0000880631 wt:OtherServicesIncomeMember 2024-01-01 2024-03-31 0000880631 2024-01-01 2024-03-31 0000880631 us-gaap:CommonStockMember 2024-12-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000880631 us-gaap:RetainedEarningsUnappropriatedMember 2024-12-31 0000880631 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000880631 us-gaap:RetainedEarningsUnappropriatedMember 2025-01-01 2025-03-31 0000880631 us-gaap:CommonStockMember 2025-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000880631 us-gaap:RetainedEarningsUnappropriatedMember 2025-03-31 0000880631 us-gaap:CommonStockMember 2023-12-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000880631 us-gaap:RetainedEarningsUnappropriatedMember 2023-12-31 0000880631 2023-12-31 0000880631 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000880631 us-gaap:RetainedEarningsUnappropriatedMember 2024-01-01 2024-03-31 0000880631 us-gaap:CommonStockMember 2024-03-31 0000880631 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000880631 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000880631 us-gaap:RetainedEarningsUnappropriatedMember 2024-03-31 0000880631 2024-03-31 0000880631 srt:MinimumMember us-gaap:EquipmentMember 2025-03-31 0000880631 srt:MaximumMember us-gaap:EquipmentMember 2025-03-31 0000880631 us-gaap:SoftwareDevelopmentMember 2025-03-31 0000880631 wt:TwoFinancialInstitutionsMember 2025-03-31 0000880631 wt:TwoFinancialInstitutionsMember 2024-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedOptionsMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedOptionsMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedOptionsMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedOptionsMember 2025-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:PassthroughGSEsMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember wt:PassthroughGSEsMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember wt:PassthroughGSEsMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember wt:PassthroughGSEsMember 2025-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2025-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2025-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2025-03-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2025-03-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ExchangeTradedFundsMember 2024-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember wt:PassthroughGSEsMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember wt:PassthroughGSEsMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember wt:PassthroughGSEsMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember wt:PassthroughGSEsMember 2024-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember 2024-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2024-12-31 0000880631 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeInvestmentsMember 2024-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000880631 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0000880631 wt:FnalityInternationalLimitedBOnePreferenceSharesMember us-gaap:FairValueMeasurementsNonrecurringMember 2024-12-31 0000880631 wt:FnalityInternationalLimitedBOnePreferenceSharesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2024-12-31 0000880631 wt:FnalityInternationalLimitedBOnePreferenceSharesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2024-12-31 0000880631 wt:FnalityInternationalLimitedBOnePreferenceSharesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2024-12-31 0000880631 wt:TradingSecuritiesMember 2025-03-31 0000880631 wt:TradingSecuritiesMember 2024-12-31 0000880631 wt:OtherAssetsseedCapitalWisdomTreeDigitalFundsMember 2025-03-31 0000880631 wt:OtherAssetsseedCapitalWisdomTreeDigitalFundsMember 2024-12-31 0000880631 wt:FnalityInternationalLimitedMember 2025-01-01 2025-03-31 0000880631 wt:FnalityInternationalLimitedMember 2024-01-01 2024-03-31 0000880631 2024-10-02 2024-10-02 0000880631 wt:SubtotalFnalityInternationalLimitedMember 2025-03-31 0000880631 wt:SubtotalFnalityInternationalLimitedMember 2024-12-31 0000880631 wt:OtherInvestmentMember 2025-03-31 0000880631 wt:OtherInvestmentMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel3Member 2024-06-17 2024-06-17 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2025-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyEightMember 2025-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyNineMember 2025-03-31 0000880631 wt:ConvertibleNotesMember 2025-01-01 2025-03-31 0000880631 wt:ConvertibleSeniorNotesMember 2025-01-01 2025-03-31 0000880631 wt:ConvertibleSeniorNotesMember 2025-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember 2025-01-01 2025-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyNineMember 2025-01-01 2025-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyEightMember 2025-01-01 2025-03-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember 2025-03-31 0000880631 wt:ConvertibleNotesMember 2024-01-01 2024-03-31 0000880631 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2025-03-31 0000880631 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2024-12-31 0000880631 us-gaap:FairValueInputsLevel2Member 2025-03-31 0000880631 us-gaap:FairValueInputsLevel2Member 2024-12-31 0000880631 wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyEightMember 2024-01-01 2024-12-31 0000880631 wt:TwoThousandAndTwentySixNoteMember 2025-01-01 2025-03-31 0000880631 wt:TwoThousandAndTwentyEightNotesMember 2025-01-01 2025-03-31 0000880631 wt:TwoThousandAndTwentyNineNotesMember 2025-01-01 2025-03-31 0000880631 wt:TwoThousandAndTwentySixNoteMember 2025-03-31 0000880631 wt:TwoThousandAndTwentyEightNotesMember 2025-03-31 0000880631 wt:TwoThousandAndTwentyNineNotesMember 2025-03-31 0000880631 wt:TwoThousandTwentySixMember 2025-03-31 0000880631 wt:TwoThousandTwentyEightMember 2025-03-31 0000880631 wt:TwoThousandTwentyNineMember 2025-03-31 0000880631 wt:ConvertibleNotesMember 2025-03-31 0000880631 wt:TwoThousandTwentySixMember 2024-12-31 0000880631 wt:TwoThousandTwentyEightMember 2024-12-31 0000880631 wt:TwoThousandTwentyNineMember 2024-12-31 0000880631 wt:ConvertibleNotesMember 2024-12-31 0000880631 us-gaap:SeriesCPreferredStockMember 2023-11-20 0000880631 2023-11-20 0000880631 2023-11-20 2023-11-20 0000880631 wt:GBHMember 2023-11-20 2023-11-20 0000880631 2023-07-01 2023-07-31 0000880631 wt:SubtotalFnalityInternationalLimitedMember 2025-03-31 0000880631 wt:SubtotalFnalityInternationalLimitedMember 2024-12-31 0000880631 wt:OtherInvestmentMember 2025-03-31 0000880631 wt:OtherInvestmentMember 2024-12-31 0000880631 wt:MaximumExposureToLossMember 2025-03-31 0000880631 wt:MaximumExposureToLossMember 2024-12-31 0000880631 wt:OtherRevenuesMember 2025-01-01 2025-03-31 0000880631 wt:OtherRevenuesMember 2024-01-01 2024-03-31 0000880631 country:US 2025-01-01 2025-03-31 0000880631 country:US 2024-01-01 2024-03-31 0000880631 country:JE 2025-01-01 2025-03-31 0000880631 country:JE 2024-01-01 2024-03-31 0000880631 country:IE 2025-01-01 2025-03-31 0000880631 country:IE 2024-01-01 2024-03-31 0000880631 wt:WisdomTreeProductsMember 2025-03-31 0000880631 wt:WisdomTreeProductsMember 2024-12-31 0000880631 wt:AffiliatedDigitalFundsMember wt:WisdomTreeProductsMember 2025-03-31 0000880631 wt:AffiliatedDigitalFundsMember wt:WisdomTreeProductsMember 2024-12-31 0000880631 wt:WisdomTreeProductsMember 2025-01-01 2025-03-31 0000880631 wt:WisdomTreeProductsMember 2024-01-01 2024-03-31 0000880631 us-gaap:RelatedPartyMember wt:ReceivableFromWTTMember 2025-03-31 0000880631 us-gaap:RelatedPartyMember wt:ReceivableFromWTTMember 2024-12-31 0000880631 us-gaap:RelatedPartyMember wt:ReceivableFromManJerIssuersMember 2025-03-31 0000880631 us-gaap:RelatedPartyMember wt:ReceivableFromManJerIssuersMember 2024-12-31 0000880631 us-gaap:RelatedPartyMember wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember 2025-03-31 0000880631 us-gaap:RelatedPartyMember wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember 2024-12-31 0000880631 us-gaap:RelatedPartyMember 2025-03-31 0000880631 us-gaap:RelatedPartyMember 2024-12-31 0000880631 us-gaap:RelatedPartyMember wt:AdvisoryServicesProvidedToWTTMember 2025-01-01 2025-03-31 0000880631 us-gaap:RelatedPartyMember wt:AdvisoryServicesProvidedToWTTMember 2024-01-01 2024-03-31 0000880631 us-gaap:RelatedPartyMember wt:AdvisoryServicesProvidedToManJerIssuersMember 2025-01-01 2025-03-31 0000880631 us-gaap:RelatedPartyMember wt:AdvisoryServicesProvidedToManJerIssuersMember 2024-01-01 2024-03-31 0000880631 us-gaap:RelatedPartyMember wt:AdvisoryServicesProvidedToWMAIAndWTICAVMember 2025-01-01 2025-03-31 0000880631 us-gaap:RelatedPartyMember wt:AdvisoryServicesProvidedToWMAIAndWTICAVMember 2024-01-01 2024-03-31 0000880631 us-gaap:RelatedPartyMember 2025-01-01 2025-03-31 0000880631 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0000880631 2022-07-15 2022-07-15 0000880631 us-gaap:StockOptionMember 2025-01-01 2025-03-31 0000880631 srt:MinimumMember wt:PerformanceBasedRestrictedStockUnitMember wt:VestRangePercentageMember 2025-01-01 2025-03-31 0000880631 srt:MaximumMember wt:PerformanceBasedRestrictedStockUnitMember wt:VestRangePercentageMember 2025-01-01 2025-03-31 0000880631 srt:MinimumMember wt:PerformanceBasedRestrictedStockUnitMember 2025-01-01 2025-03-31 0000880631 srt:MaximumMember wt:PerformanceBasedRestrictedStockUnitMember 2025-01-01 2025-03-31 0000880631 wt:PerformanceBasedRestrictedStockUnitMember 2025-01-01 2025-03-31 0000880631 wt:PerformanceBasedRestrictedStockUnitMember wt:VestRangePercentageMember 2025-01-01 2025-03-31 0000880631 us-gaap:RestrictedStockUnitsRSUMember 2025-03-31 0000880631 wt:EmployeesAndDirectorsMember 2025-03-31 0000880631 wt:EmployeesAndDirectorsMember 2025-01-01 2025-03-31 0000880631 us-gaap:RestrictedStockMember 2024-12-31 0000880631 us-gaap:RestrictedStockUnitsRSUMember 2024-12-31 0000880631 wt:PerformanceBasedRestrictedStockUnitMember 2024-12-31 0000880631 us-gaap:RestrictedStockMember 2025-01-01 2025-03-31 0000880631 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0000880631 us-gaap:RestrictedStockMember 2025-03-31 0000880631 wt:PerformanceBasedRestrictedStockUnitMember 2025-03-31 0000880631 us-gaap:SeriesAPreferredStockMember 2025-01-01 2025-03-31 0000880631 us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0000880631 country:US 2025-03-31 0000880631 srt:EuropeMember 2025-03-31 0000880631 us-gaap:AccountingStandardsUpdate202309Member us-gaap:DomesticCountryMember 2025-01-01 2025-03-31 0000880631 us-gaap:AccountingStandardsUpdate202309Member us-gaap:StateAndLocalJurisdictionMember 2025-01-01 2025-03-31 0000880631 us-gaap:AccountingStandardsUpdate202309Member us-gaap:ForeignCountryMember 2025-01-01 2025-03-31 0000880631 us-gaap:AccountingStandardsUpdate202309Member us-gaap:ForeignTaxJurisdictionOtherMember 2025-01-01 2025-03-31 0000880631 us-gaap:AccountingStandardsUpdate202309Member 2025-01-01 2025-03-31 0000880631 srt:MinimumMember 2022-02-22 0000880631 srt:MaximumMember 2022-02-22 0000880631 2022-02-22 2022-02-22 0000880631 srt:MinimumMember 2025-02-24 0000880631 srt:MaximumMember 2025-02-24 0000880631 2025-02-24 2025-02-24 0000880631 srt:BoardOfDirectorsChairmanMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000880631 srt:BoardOfDirectorsChairmanMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000880631 wt:StockAcquisitionsMember 2025-03-31 0000880631 wt:ETFSAcquisitionMember 2025-01-01 2025-03-31 0000880631 wt:ETFSAcquisitionMember 2018-04-11 0000880631 us-gaap:SoftwareDevelopmentMember 2025-01-01 2025-03-31 0000880631 us-gaap:SoftwareDevelopmentMember 2024-01-01 2024-03-31 0000880631 wt:ETFSAcquisitionMember 2025-03-31 0000880631 us-gaap:SoftwareDevelopmentMember 2025-03-31 0000880631 wt:ETFSAcquisitionMember 2024-12-31 0000880631 us-gaap:SoftwareDevelopmentMember 2024-12-31 0000880631 srt:ChiefOperatingOfficerMember 2024-01-01 2024-03-31 0000880631 2025-02-25 2025-02-25 0000880631 wt:MrLilienMember 2025-02-25 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:EUR iso4217:GMD